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Abstract 
 As the health care system continues to evolve, the challenges related to 
successfully treating chronic conditions persist.  To address these challenges, 
supplemental treatments, such as the shared medical appointment (SMA) and behavioral 
health care (BHC), have been implemented to provide patients with additional levels of 
psychoeducation and support in addition to treatment by their physician.  The total 
sample used in this study was 118.  The purpose of this study was to evaluate the 
effectiveness of integrated primary care (IPC), IPC plus SMA, and IPC plus BHC to 
determine if supplemental treatment combined with IPC produced greater improvement 
in patients with diabetes.  The measures in this study were body mass index (BMI), 
systolic blood pressure, diastolic blood pressure, hemoglobin A1C (HbA1c), high-density 
lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and total 
cholesterol.  To test this hypothesis, a 3 x 2 analysis of variance with repeated measures 
on one factor was conducted.  The independent variable had three levels describing the 
treatment type (integrated primary care (IPC), IPC plus SMA, and IPC plus behavioral 
health).  Outcome measures were examined at pre and posttest to determine if the 
conditions considered to be more integrated showed stronger treatment effects as 
measured by the outcome variables.  Results indicated that none of the seven outcome 
variables showed significant improvement as a result of receiving a supplemental level of 
care in addition to IPC.  However, four of the seven variables improved over time 
regardless of treatment condition.  This finding suggests that perhaps the addition of 
SMA and BHC did not add anything over and above IPC only.  Careful consideration 
should be applied to these results, because these particular patients were treated 
according to the IPC model.  Therefore, physicians may have actually been providing 
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patients with similar interventions across conditions, such as psychoeducation and 
motivational interviewing, during their routine doctor visits.  Thus, patients who received 
IPC may have actually received components included in the other two groups.   
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An Evaluation of Integrated Primary Care (IPC), IPC Plus Shared Medical 
Appointments, and IPC Plus Individual Behavioral Health Care on Diabetes Management 
Chapter 1: Introduction 
Statement of the Problem 
In 1994, approximately 2.5% of the population had been diagnosed with diabetes 
(Sidney et al., 2016).  By 2015, this total increased to 9.4% of the population, meaning 
that 30.3 million Americans had a diagnosis of diabetes, and another 84.1 million 
manifested prediabetes, a condition which, left untreated, often leads to Type 2 diabetes 
(CDC, 2017).  A major factor in the unexpected increase was the estimated number of 
individuals currently living with undiagnosed diabetes.  The Center for Disease Control 
(2012) estimated that 8.1 million Americans live with undiagnosed diabetes.  An 
estimated 1.5 million new cases of diabetes were diagnosed in Americans over the age of 
18 in 2015 (CDC, 2017).  Moreover, nearly one in four adults were aware they had 
diabetes.  Rates of diabetes in the United States vary significantly by ethnicity, with 
American Indians/Alaska Natives (15.1%), non-Hispanic blacks (12.7%), and Hispanics 
(12.1%) having the three highest rates (CDC, 2017).  As the number of individuals 
diagnosed rises each year, so does the risk of developing serious co-occurring health 
conditions.   
In 2015, diabetes was the seventh-leading cause of death in the United States 
(CDC, 2017).  This statistic indicates the complexity of managing a chronic illness like 
diabetes.  One major contributing factor is improper blood glucose monitoring, which 
may result in hypoglycemia.  When hypoglycemia develops, it contributes to serious 
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health consequences, including unconsciousness, seizures, or death (CDC, 2012).  
Additional complications resulting from poorly managed diabetes include high blood 
pressure, high LDL cholesterol, heart disease and stroke, blindness and eye problems, 
kidney disease, and amputations.  The more complications that arise, the more money is 
spent attempting to treat them.   
The estimated medical cost of treating diabetes in the year 2007 was $116 billion 
(Narayan et al., 2006).  Since 2007, the total direct and indirect estimated cost of treating 
diabetes was $245 billion (CDC, 2012).  By the year 2050, that cost is expected to double 
(Egede et al., 2012).  The already expensive course of treatment for diabetes is further 
complicated by rates of adherence and nonadherence.  As used in this study, adherence 
to medical advice is defined as follows:  
[Adherence refers to] whether a patient follows the directions offered by his/her 
physician in regard to performing some behaviors, or sequence of behavioral 
tasks, designed to ultimately improve or maintain the health or mental health of 
the patient, or prevent the development of illness and disease (DiTomasso, 
Chiumento, Singer, & Bullock, 2009, p. 291.)   
The most common forms of treatment in the United States are oral medications 
and insulin injections (Egede et al., 2012).  However, more than one-third of patients with 
diabetes fail to achieve the full benefit of medication as a result of nonadherence (Egede 
et al., 2012).  Although prescribed treatment regimens by physicians are empirically 
based, patients are responsible for performing the necessary self-care behaviors to 
successfully manage their diabetes.   
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Once diagnosed with diabetes, an individual must perform a multitude of self-care 
behaviors to prevent serious health consequences or even mortality.  As a self-care 
disease, patients are expected to become active participants in their diabetes management.  
These self-care behaviors encompass multiple domains and include physical activity, 
medication adherence, glucose monitoring, symptom management, and proper dietary 
choices (Weinberger, Butler, Welch, & Greca, 2005).  However, patients may become 
overwhelmed by the treatment regimen, and their ability to adhere to their self-care plan 
may be compromised.  As individuals with diabetes fail to keep up with their self-care, 
the disease progresses and additional complications arise.  For some individuals, the task 
of simply injecting oneself is daunting.  Thus, providing patients with self-management 
education and the assistance of a behavioral support team can increase the likelihood of 
adherence to a prescribed treatment regimen (Funnell et al., 2009).  The involvement of a 
multidisciplinary approach allows health care professionals to provide necessary 
education specifically tailored to the needs of each patient.  This is important, because 
patients’ involvement in their own treatment plan has been shown to improve patient self-
efficacy in carrying out the plan (Funnell et al., 2009).  Furthermore, continuity of care, 
meaning that the patient sees the same physician on each visit, has been demonstrated to 
enhance adherence (Kripalani et al., 2007).  Although variables associated with improved 
treatment adherence have been identified, rates of adherence remain below the preferred 
level.   
For treatment regimens involving lifestyle changes, the nonadherence rate stands 
at 50% (Delamater, 2006).  The reported rate of adherence to oral diabetes medication 
ranges between 36% and 87% (Osborn & Egede, 2012).  Furthermore, although a 65% 
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adherence rate was reported for diet change, a 19% adherence rate to an exercise regimen 
was found in patients with diabetes (Delamater, 2006).  Several contributing factors to 
nonadherence have been identified.   
In their now-classic work, Meichenbaum and Turk (1987) identified multiple 
domains affecting adherence, including patient variables, physician variables, and 
treatment variables.  The construct of patient beliefs lies in the domain of patient 
variables.  Patient beliefs about the efficacy of a specific treatment can impact the 
potential success of an intervention.  Patient beliefs may be erroneous or contain 
distortions, but as the physician does not typically address these misconceptions, 
nonadherence is more likely to occur (Meichenbaum & Turk, 1987).  Erroneous patient 
beliefs, including little-perceived control of the body, negative self-perception, and 
external locus of control, have been reported to increase the risk of nonadherence 
(Farrell, Hains, Davies, Smith, & Parton, 2004.)  Moreover, higher levels of general 
stress are also believed to negatively affect adherence behaviors, such as adequately 
monitoring blood glucose (Farrell et al., 2004).  The professional relationship further 
impacts a patient’s belief in his/her ability to carry out a physician’s recommendations.   
The next treatment variable contributing to nonadherence results from a a rupture 
in the patient-physician relationship.  An underdeveloped relationship between patient 
and physician may result in the implementation of an intervention that the patient 
perceives as too complex to carry out successfully.  When physicians prescribe a complex 
course of treatment, rates of adherence worsen (Meichenbaum & Turk, 1987).  Treatment 
complexity is defined as how medications are administered, the number of medications, 
the frequency of administration, and the directions for taking medication (deVries, et al., 
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2014).  Thus, treatment complexity diminishes a patients’ ability to recall the information 
given to them by their physician.  In addition to understanding a patient’s capacity to 
carry out a treatment regimen, physicians must also monitor a patient’s response to that 
regimen.   
A treatment plan’s duration also affects adherence.  When a particular treatment 
has continued for an extended period of time and did not result in the desired treatment 
effect, nonadherence was more likely to occur (Meichenbaum & Turk, 1987).  Both 
patient and provider variables contribute to nonadherence; however, a patient’s 
nonadherence is not necessarily intentional. 
Unintentional nonadherence occurs when individuals ability to adhere is deficient 
because of a fundamental misunderstanding of the regimen (deVries et al., 2014).  
Therefore, the complexity of a particular regimen should be considered before 
prescribing it to a patient.  Patients who intentionally deviated from their treatment 
regimen reported a higher degree of concern about possible negative effects of treatment 
that were unaddressed (deVries et al., 2014).  To address the aforementioned obstacles 
and increase successful management of chronic illnesses, the integrated primary care 
(IPC) model was developed.   
In contrast with traditional formats of health care, which blame the patient for 
nonadherence, the IPC model delivers behavioral health care in a primary care facility 
with the goal of improving patient health outcomes.  In the IPC model, behavioral health 
consultants offer support to other medical providers, with the goal of addressing the 
needs of the patient completely.  As a result of using a collaborative approach, IPC 
enables earlier detection of and intervention in behavioral health complications (Bridges 
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et al., 2015).   Patient follow-up visits are often shorter and less frequent, another 
significant improvement in an integrated-care setting.    
According to the IPC model, the physician first introduces the concept of 
integrated care.   The process of a warm handoff follows.  A warm handoff entails a face-
to-face transfer of a patient from one behavioral health team member to another.  
Furthermore, the warm handoff introduces the behavioral health consultant to the patient 
and permits the description of the patient’s presenting concerns (Bridges et al., 2015).  
The warm handoff has improved communication and coordination of care between 
providers in the same setting (Bryan, Corso, & Macalanda, 2014).  Physicians also 
indicated a preference for using the warm handoff to introduce behavioral health 
consultants at times when they had a high volume of patients (Gouge, Polaha, & Powers, 
2014).   
Another pillar of an integrated health care system is the shared medical 
appointment (SMA).  SMAs last between 60 and 120 minutes, and typically bring 
together the patient and his or her health care team, which may include the primary care 
physician and a behavioral health professional psychologist, social worker, or nurse 
practitioner (Kirsch et al., 2007).  SMAs allow for improved patient access, increased 
satisfaction, reduced costs, improved clinical outcomes for medical procedures, and a 
reduced number of hospitalizations (Bronson & Maxwell, 2004).  Areas of overall 
improvement may include body weight, blood pressure, cholesterol, blood sugar 
monitoring, adherence to medical recommendations, and appointment keeping. 
 Increased access to behavioral health care is an important factor addressed by the 
IPC model, due to the fact that an estimated 50 to 70% of individuals receive treatment 
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for co-occurring health issues by their primary care physician (Curtis & Christian, 2012).  
The integrated care model addresses this situation through colocation of health care 
providers.  Colocation means that behavioral health consultants are available to meet with 
referred patients on the same day that they visit their primary care physician.  Most times, 
the patients are able to remain in the same exam room throughout their visit (Bridges et 
al., 2015).  Another benefit of colocation is that treatment plans can be specifically 
tailored to the patient, because a multitude of variables can now be addressed.  Tailoring 
the treatment plan to specifically meet individual patient needs is critical, because 
patients have more control over possible interventions and play an important role in 
determining the likelihood of follow-through.  Evidence indicates that patients who are 
involved in creating their treatment plans are more likely to adhere to them.  Additional 
studies have indicated that active patient participation in treatment planning shown to 
improved adherence.   
 The most frequently used treatments associated with improving adherence in an 
integrated behavioral health center are action-oriented, evidence-based interventions 
consistent with a cognitive behavioral orientation (Bridges et al., 2015).  Furthermore, 
these interventions ensure that patients are more than passive observers of their treatment.  
An increased number of treatment options are positively associated with an enhanced 
initial buy-in to treatment, increased likelihood of following through with treatment, and 
better adherence to medication regimens (Davidson, Tondora, Miller, & O’Connell, 
2015).  The enhanced treatment provided by the IBHC model not only results in stronger 
adherence rates, but it also reduces the cost of managing diabetes.   
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The integrated care approach focuses on preventing illness rather than managing 
it.  The goal is a preventative approach aimed at treating symptoms early, as opposed to 
treating subsequent complications.  The Affordable Care Act (ACA), enacted in 2010, 
provides incentives to hospitals that greatly reduce their number of readmissions, but 
hospitals that rank in the top 25% will face sanctions (Orszag & Emanuel, 2010).  In a 
similar fashion, physicians and hospitals that coordinate patient care with other 
professionals and prevent hospitalizations will be rewarded.  The goal is to reduce the use 
of ineffective treatment approaches while increasing the use of cost-effective treatments.   
Several studies have demonstrated the utility of the integrated behavioral health 
care model.  The Johns Hopkins School of Medicine conducted a study over the course of 
eight months, using an integrated-care team consisting of registered nurses and primary 
care physicians to implement an integrated-care model.  Patients were taught self-
management skills, which included skills for early detection of symptom exacerbation 
(Grumbach & Grundy, 2010).  Results of the study included a 24% reduction in total 
days hospitalized, 15% fewer visits to the emergency room, a 37% decrease in days in a 
skilled nursing facility, and an annual savings of $75,000 per nurse deployed by the 
practice (Leff et al., 2009).  Another study, conducted by BlueCross BlueShield, 
implemented the use of the patient-centered medical home (PCMH), a visit to a patient’s 
home by a collaborative behavioral health care team targeting diabetes.  Patients 
participating in the PCMH showed a 36.3% decrease in inpatient hospitalizations after 
one year compared to the control group (Grumbach & Grundy, 2010).  The PCMH 
patients also significantly improved on measures of LDL cholesterol levels, eye exams, 
reduced BMI, consistent HbA1c testing, and a HbA1c level of less than 8 (Grumbach & 
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Grundy, 2010).  These studies indicate that collaboration between physicians and 
behavioral-health consultants produces desirable results, including diminished 
exacerbation of symptoms, reduced financial burden, fewer inpatient hospitalizations, and 
enhanced treatment progress.   
Purpose of the Study 
The traditional primary care visit consists of a one-on-one meeting between a 
patient and clinician.  However, this format may be inappropriate for addressing such 
chronic disease as diabetes, which requires complex ongoing treatment (Egger et al., 
2014).   An integrated primary care model combats this inadequacy by allowing health 
care professionals to collaborate and address fully the multitude of presenting problems 
related to diabetes (Blount, 2003).  The purpose of the present study was to evaluate the 
treatment effects of integrated primary care plus shared medical appointment, integrated 
primary care plus behavioral health care, and integrated primary care alone, as measured 
by a number of health outcomes.   
Review of the Literature  
Diabetes Mellitus  
Diabetes mellitus is a chronic illness characterized by the body’s inability to 
produce or properly use insulin.  The four clinical classes of diabetes mellitus are Type 1, 
Type 2, gestational, and other types of diabetes caused by genetic factors, such as 
pancreatic disease or genetic deficits in insulin (ADA, 2010).   
Type 1  
Type 1 diabetes commonly manifests in the early stages of life and is considered a 
chronic condition.  It is characterized by destruction of beta cells in the pancreas that 
INTEGRATED PRIMARY CARE  10  2 
 
 
naturally produce insulin and commonly results in an absolute deficiency of insulin 
(Wolsdorf et al., 2007) Type 1 diabetes accounts for approximately 5% of diabetes 
diagnoses (Wolsdorf et al., 2007).  Symptoms of Type 1 diabetes include increases in 
appetite, weight loss, and urination, decreased energy, irritability, muscle cramps, 
changes in vision, anxiety, altered ability to perform at school or work, headaches, chest 
pain, breathing difficulty, stomach pain, nausea and diarrhea or constipation.   
Type 2 
Type 2 diabetes is the most common type, affecting 90-95% of individuals with a 
diabetes diagnosis (Quinn, 2004).  Type 2 differs from Type 1 in that the pancreas still 
produces insulin, but the insulin is misused.  As a result, Type 2 diabetes may also be 
referred to as insulin resistance.  Over time, the pancreas becomes unable to produce the 
necessary amounts of insulin needed to properly regulate blood glucose levels.  
Symptoms of Type 2 diabetes include frequent urination, increased appetite, fatigue, 
weight loss, weakness, and frequent infections (ADA, 2012).  
Prevalence rates 
 As of 2002, approximately 6% of the population of the United States had 
diabetes, and it ranked as the nation’s seventh-leading cause of death (American Journal 
of Preventative Medicine, 2002).  Approximately 41 million Americans are at risk of 
becoming diabetic.  Age has been shown to be a contributing factor to diabetes diagnoses, 
as evidenced by the approximately 20% of Americans over 65 years of age who are 
affected (Quinn, 2004).  Approximately 151,000 people younger than age 20 years are 
diagnosed with diabetes each year, and one of every 400 children is diagnosed with Type 
1 or juvenile diabetes (Quinn, 2004).  The Centers for Disease Control and Prevention 
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(2003) has estimated that as the population ages, the number of diabetes diagnoses will 
increase by 165% between 2000 and 2050.  The large number of individuals diagnosed 
with diabetes, combined with the estimated increase in diagnoses, highlights the 
importance of utilizing variables proven to facilitate adherence.   
Adherence in Patients with Diabetes 
In order to successfully implement a treatment regimen, adherence on the part of 
the patient is a critical treatment variable.  Identifying potential obstacles aids the creation 
of a strategy to overcome these barriers, thus increasing adherence.   
Medical adherence is defined as follows: 
Whether a patient follows the directions offered by his/her physician in regard to 
performing some behaviors, or sequence of behavioral tasks, designed to 
ultimately improve or maintain the health or mental health of the patient, or 
prevent the development of illness and disease (DiTomasso, Chiumento et al., 
2009, p.  291.)   
Several factors, including the patient, physician-patient relationship, treatment 
regimen, and characteristics of the treatment setting, influence adherence (DiTomasso, 
Chiumento et al., 2009).  Therefore, the use of formal assessment on an individualized 
basis is a critical means of determining potential obstacles to adherence.  Clinicians 
trained in CBT may perform the assessment, because that training has specifically 
prepared them to identify these factors (DiTomasso, Chiumento et al., 2009).  Physicians, 
on the other hand, are likely to be more astute at determining whether or not patients are 
adhering to their prescribed regimens.  Together, the CBT clinician and physician would 
be wise to review medical records and charts to determine causal factors.  Special 
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attention should be paid to the patient’s attitudes, beliefs, behaviors, feelings, situational 
factors, and any other potential obstacles (DiTomasso, Chiumento et al., 2009).   
Economic Costs Associated with Diabetes  
According to the ADA (2012), three categories of indirect costs are attributed to 
diabetes: absenteeism, presenteeism, and inability to work.  Absenteeism is defined as the 
number of days an individual does not attend work due to poor health.  Individuals with 
diabetes have been found to miss more days of work than the general population (CDC, 
2013).  Presenteeism means that although individuals are present at work, their health 
prevents them from performing to their full potential.  Lost productivity at work or 
absenteeism was estimated to produce a loss in earning potential of approximately $5 
billion.  Among the population of individuals with diabetes, medical expenditures were 
approximately 2.3 times higher than if they did not suffer from the disease (ADA, 2007).  
As the number of diabetes diagnoses increase, the productivity of the workforce 
decreases.   
The ADA (2012) estimated that the total number of individuals diagnosed with 
diabetes approached 17.5 million, and the number of individuals diagnosed with diabetes 
in the year 2050 is expected to increase significantly (Narayan, Boyle, Geiss, Saaddine, 
& Thompson, 2006).  In 2012, the estimated total cost of diabetes treatment was $245 
billion.  This total had risen sharply since 2007, when the estimated cost was $174 billion 
(ADA, 2007).  The $245 billion included $176 billion in excess medical expenditures and 
$69 billion associated with loss of productivity (ADA, 2007).  For every $5 spent on 
providing health care, $1 was spent on  individuals with diabetes (ADA, 2007).   
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Results of the 2012 study by the ADA estimated that individuals with diabetes are 
2.4 times more likely to be forced out of the workforce and collect disability.  Reduced 
productivity occurs in individuals with diabetes not only in the workforce but also outside 
the workforce.  Examples of reduced productivity outside the workplace include for 
family members providing care for individuals with diabetes, inability to perform 
household chores, and lost activity in the community.  A final consideration is that 
premature mortality is more likely to occur in individuals with diabetes, eliminating 
future economic contributions by them (ADA, 2012).   
Medical Consequences Associated with Diabetes 
Foot problems  
Diabetes is responsible for more than 50% of lower extremity amputations 
(Reiber, Lipsky, & Gibbons, 1998).  In a population of Medicare patients with diabetes, 
the risk of having a lower limb amputated was approximately 10% (Wrobel, Mayfield, & 
Reiber, 2001).  Contrary to the popular belief that amputations of the foot are caused by 
vascular-related complications, the initial indicator of an infection begins with a foot 
ulcer (Ulbrecht, Cavanagh, & Caputo, 2004).  The development of foot ulcers is caused 
by loss of protective sensations (LOPS).  LOPS involves a sensory loss in the foot, which 
permits skin injury or irritation without the accompanying pain that would typically be 
caused by these conditions (Ulbrecht et al., 2004).  The problem is further complicated 
because patients often believe their ability to sense pain has not changed, making them 
less likely to take action to prevent injury from escalating to a higher level of severity, or 
more likely to continue behavior that exacerbates their foot’s condition.   
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In order for a diabetes-related foot problem to devolve into an amputation, three 
conditions contribute to the loss of protective sensations that eventually leads to skin 
breakdown:  dorsal deformity, high plantar pressure, and dry skin.  The dorsal region is 
the area of the foot most susceptible to LOPS (Ubrecht et al., 2004).  A shoe that no 
longer fits properly because of swelling in the foot is a major culprit in skin breakdown in 
the dorsal region.  Another trigger is dry skin on the heel of the foot that may crack 
easily, creating a locus of infection.  Once infection and/or ischemia occurs as a result of 
the breakdown of skin, amputation may be the only solution (Ubrecht et al., 2004).   
Eye complications 
 Diabetic retinopathy is characterized by the growth of new blood vessels on the 
retina and posterior surface of the vitreous, and it is more likely to occur in individuals 
with Type 1 diabetes (Fong et al., 2004).  Diabetic retinopathy is defined by the ADA 
(2011) as “damage to the small blood vessels in the eye that can lead to vision problems.”  
Macular edema is another complication, which is characterized by thickening of the 
retina resulting from leaky blood vessels (Fong et al., 2004).  Diabetic retinopathy is the 
leading cause of legal blindness in individuals aged 20 to 74 years in the United States 
(ADA, 2011; Zhang et al., 2010).  Risk factors increasing the likelihood of developing 
retinopathy include high blood glucose, high blood pressure, and smoking (ADA, 2011).   
Individuals diagnosed with Type 2 diabetes show a rate of retinopathy of over 
60% (Fong et al., 2004).  The Type 1 diabetes population infrequently develops 
retinopathy in the first three to five years after diagnosis.  However, over the course of 
the next two decades of their lives, nearly all of the Type 1 population will develop 
retinopathy (Fong et al., 2004).  Diabetic retinopathy is linked to several conditions that 
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cause loss of vision: detachment of the retina, parietal or vitreous hemorrhage, 
glaucoma, and macular edema (Fong et al., 2004).  Diabetic retinopathy is complicated 
by the fact that symptoms do not often emerge until the condition is well advanced.  
The two main forms of retinopathy caused by diabetes are nonproliferative and 
proliferative.  Nonproliferative retinopathy is also known as background retinopathy.  
More common than proliferative retinopathy, it is considered as the less serious of the 
two types (ADA, 2011).  It results in the closing off or weakening of blood vessels in the 
eye, causing blood vessels to leak blood, fat, and fluid into the eye (ADA, 2011).  
Nonproliferative retinopathy typically presents as blurred vision, but blindness is 
uncommon (ADA, 2011).  The second type, proliferative retinopathy, causes the 
formation of new and unnecessary blood vessels that do not grow in the same way as 
normal blood vessels (ADA, 2011).  The newly formed blood vessels are fragile and 
easily ruptured during such activities as sleeping or exercising (ADA, 2011; Butler et al., 
2005).  Once the blood vessels are ruptured, the eye fills with blood, blocking light from 
entering the retina; eventually scar tissue forms that shrinks, tearing the retina to and 
potentially causing blindness (ADA, 2011).   
Neuropathy 
 High levels of blood glucose can cause neuropathy either directly or by 
dramatically slowing or stopping blood flow (ADA, 2011).  The three types of 
neuropathy present in individuals with diabetes are peripheral, autonomic, and focal.  
Diabetic peripheral neuropathy is defined as peripheral, somatic, or autonomic nerve 
damage attributable solely to diabetes mellitus (Pinzur, 2011).  It alters an individual’s 
ability to experience sensations in their extremities, most commonly in the feet, but also 
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occurring in the fingers (ADA, 2011).  In some individuals, the sensation is decreased to 
such an extent that they are unable to feel painful stimuli, but in others pain intensifies to 
the degree that anything covering their feet becomes painful (ADA, 2011).  Neuropathy 
often takes many years to develop among individuals with diabetes who have had 
consistently high glucose levels (ADA, 2011).   
The number of individuals with diabetes who experience peripheral neuropathy is 
estimated as between 60 to 70% (ADA, 2011).  It is the most common type of neuropathy 
among individuals with diabetes and the leading cause of amputation (Davies et al., 
2006).  Two major predictors have been identified as direct contributors to peripheral 
neuropathy: diabetes and metabolic control.  The development of peripheral neuropathy 
is likely also facilitated by nephropathy, proliferative retinopathy, cardiovascular disease, 
and genetic predisposition (Pinzur, 2011).  Peripheral neuropathy may present as 
asymptomatic and comprises both positive and negative symptoms.  Negative symptoms 
include a loss of sensation and/or strength; positive symptoms include pain or the feeling 
of something pricking the skin (Davies et al., 2006).   
The second type of neuropathy is autonomic neuropathy.  Autonomic neuropathy 
damages autonomic nerves in the body, which are responsible for an individual’s heart 
beating or digestion (ADA, 2011).  Damage to these autonomic nerves presents in 
numerous ways, including bladder problems, erectile dysfunction, vaginal dryness and 
decreased sexual desire in women, as well as blood pressure, skin, and heart problems 
(ADA, 2011).   
 The third type of neuropathy is focal neuropathy, which is characterized by 
damage to a single nerve or group of nerves (ADA, 2011).  It develops similarly to the 
INTEGRATED PRIMARY CARE  17  2 
 
 
other types in that blockage of blood to a nerve is often responsible.  Focal neuropathy is 
not a chronic condition,  typically lasting anywhere between two and 18 weeks.  The best 
known type of focal neuropathy is carpal tunnel syndrome, which occurs more often in 
individuals with diabetes.  Carpal tunnel syndrome results in a tingling or burning 
sensation or numbness (ADA, 2011).   
Diabetic ketoacidosis (DKA) 
 Diabetic ketoacidosis is a condition that causes individuals with diabetes to enter 
a diabetic coma, which involves passing out for an extended period of time (ADA, 2015).  
Diabetic ketoacidosis occurs when cells in the body do not receive the amount of glucose 
needed for energy.  The necessary amount of glucose is not delivered, because the body 
is not producing enough insulin to use the glucose.  The body then begins to burn fat to 
produce energy (ADA, 2015).  The process of burning fat to provide energy results in the 
production of ketones.  As ketones build up, blood becomes more acidic, poisoning the 
body from the inside.  DKA, the development of high levels of ketones (ADA, 2015), is a 
slowly developing disease, and early symptoms include severe thirst or dry mouth, 
frequent urination, high blood glucose levels, and high levels of ketones in the blood 
(ADA, 2015).  As the ketoacidosis progresses, additional symptoms, such as constant 
fatigue, dry skin, nausea and vomiting, difficulty breathing, and confusion or difficulty 
paying attention, may develop (ADA, 2015).  In severe circumstances, DKA can lead to 
death. 
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Nephropathy  
Nephropathy, also known as kidney disease, is exacerbated by high blood glucose 
and hypertension (ADA, 2011).  Nephropathy results in toxins/waste remaining in the 
body, which disrupts proteins and nutrients that should remain in the bloodstream  (ADA, 
2011).  The kidneys, which are responsible for filtering waste for excretion in urine, are 
no longer capable of performing this task, resulting in chronic renal failure. 
Diabetes mellitus is the leading cause of chronic renal failure worldwide (Duran-
Salgado & Rubio-Guerra, 2014).  Diabetic nephropathy occurs in approximately 30% of  
cases of Type 1 and Type 2 diabetes and is the leading cause (43%) of end-stage renal 
disease (ESRD), the complete failure of the kidneys (ADA, 2011; Choudhury, Tuncel, & 
Levi, 2010).  In 2008, 48,374 individuals with diabetes started treatment for ESRD, and 
202,290 people with ESRD caused by diabetes survived through chronic dialysis or a 
kidney transplant (CDC, 2011).  The major reason that nephropathy often results in 
ESRD is that patients do not notice it until 80% of their kidney function has been 
compromised (CDC, 2011).   
Research has shown that individuals with Type 1 diabetes who developed diabetic 
nephropathy have a significantly higher likelihood of developing coronary heart disease.  
If an individual was born with Type 1 diabetes, the risk of developing coronary heart 
disease after suffering from nephropathy for 20 years increased by 29% (Ryden et al., 
2007).  Nephropathy has also been shown to increase the risk of stroke by a factor of 10 
(Ryden et al., 2007).  High blood pressure is a major complicating factor in both 
nephropathy and hypertension.  Therefore, lowering blood pressure is a major goal in  
reducing the risk of developing nephropathy. 
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Stroke 
The risk of ischemic stroke increases drastically for individuals with diabetes.  
The risk of stroke for individuals with diabetes is more than double that of nondiadetic 
individuals (Luitse, Biessels, Rutten, & Kappelle,  2012).  Ischemic strokes result from an 
immediate reduction in cerebral blood flow (Brott & Bogousslavsky, 2000).  In countries 
considered as high income, stroke is the second leading cause of long-term disability 
(Luitse, et al., 2012).  The mortality rate of individuals with diabetes following a stroke 
increases regardless of the person’s age, the type of stroke suffered, or the stroke’s 
severity (Bellolio, Gilmore, & Stead, 2011).   
Ongoing research is underway to determine the proper way to immediately 
manage blood sugar following a stroke.  A trial was conducted, during which intensive 
insulin treatment was compared to usual care following a stroke (Bellolio et al., 2011).  
The results indicated that intense attempts to restrict blood sugar to a tight range 
immediately after a stroke did not improve any deficits resulting from the stroke.  
However, the study found that immediately after a stroke, patients are susceptible to 
hypoglycemia, which has been shown to cause brain damage and death (Bellolio et al., 
2011).  The costs associated with diabetes are not limited to the physical arena.        
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Levels of Care  
Traditional Diabetes Management 
 Once a diagnosis of Type 1, Type 2, or gestational diabetes is established, dietary 
change becomes an intense focus of treatment.  Identifying a daily diet with the 
appropriate caloric intake based on the patient’s body weight is an important step in 
dietary change.  The diet entails closely monitoring sugar and carbohydrate intake.  The 
goal of the diet is to assist the patient in maintaining blood glucose levels within the 
normal range of 60 to 120 mg/dl.  The patient is responsible for consistently managing 
their blood glucose levels throughout the day. 
 In order to maintain appropriate levels, the patient must check his or her blood 
glucose levels on a regular basis, usually before and after meals or snacks.  Blood glucose 
control is an important predictor of many chronic complications.  Each 1% reduction in 
hemoglobin A1c over 10 years is associated with a 21% reduction in diabetes-related 
deaths, a 14% reduction of heart attacks, and a 37% reduction in microvascular 
complications (Norris, Lau, Smith, Schmid, & Engelgau, 2002).  The hemoglobin A1c 
test is used to check patients’ control of their blood glucose levels over a three-month 
period.  The recommended hemoglobin A1c level is 6.5 or below.  A hemoglobin A1c 
level in the recommended range means that the patient’s blood glucose levels are 
managed properly on a daily basis.  The usual treatment regimen involves the use of 
insulin, as well as lifestyle changes to regulate blood glucose levels.   
Patients diagnosed with Type 1 diabetes are treated with insulin injections, diet, 
and exercise.  Different types of insulin used to treat Type 1 diabetes are rapid-acting 
(Humalog), short-acting (Regular), intermediate-acting (NPH), long-acting (Ultralente), 
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and premixed (Humalog 75/25 and Humalog 50/50; Inzucchi, 2001).  A patient with 
diabetes may require rapid-acting insulin in situations in which they need to quickly 
reduce a high blood glucose level.  Insulin should be taken 5 to 15 minutes prior to or 
immediately before a meal.  When this is not possible, a patient may inject insulin 
immediately after a meal to reduce blood glucose levels (Hess-Fischl, 2004).  Short- and 
intermediate-acting insulin should be taken 30 minutes prior to meals or snacks, and 
long-acting insulin can be used once a day to help regulate blood glucose levels.  
Premixed insulin contains either regular or rapid-acting insulin.  An insulin consisting of 
a 75/25 mix of rapid-acting and regular insulin should be taken 5 to 15 minutes prior to or 
immediately following a meal.  A 50/50 insulin mix should be taken 30 minutes prior to a 
meal, because 50% is rapid-acting insulin (Hess-Fischl, 2004).  Despite the effectiveness 
of the traditional management of diabetes using medication, supplemental treatment 
alternatives are available to increase adherence to specific medication regimens. 
Three potential factors of physician-only treatment that impact successful diabetes 
treatment are beliefs, attitudes, and knowledge, patient-provider communication, and the 
health-care system (Nam, Chesla, Stotts, Kroon, Janson, 2011).  Deficits in each of these 
components underscore the need for an integrated approach to reduce potential deficits in 
individual team members.   
 A physician’s attitudes and beliefs about diabetes management can be more 
significant than  his or her knowledge about treating diabetes.  A physicians’ beliefs can 
influence the course of treatment, depending on whether or not the physician views 
diabetes as a serious illness.  One study indicated that many of the physicians polled 
considered Type 2 diabetes a nonserious disease (Puder & Keller, 2003).  The impact of a 
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perception of the illness can significantly impact the recommended course of treatment 
and treatment outcome.   The addition of behavioral health team members may offer 
additional insight and understanding to ameliorate the impact that living with diabetes has 
on an individual.   
In the health care system, upwards of 75% of individuals with diabetes receive 
treatment from only their primary care physician (Shumaker, Schron, Ockene, & McBee, 
2004).  Primary care physicians typically see a patient for 10-15 minutes, due to 
limitations imposed on them by their schedules.  At each appointment, an individual with 
diabetes has a limited amount of time to comprehend and learn to implement their 
treatment regimen.  The restrictions that physicians face have adverse effects on 
adherence rates in diabetic patients. 
Research indicates that approximately 33% of diabetic patients treated in primary 
care correctly follow their physician’s plan (Shumake, Schron, Ockene, & McBee, 2004).  
A potential explanation for this lies in the confluence of behavioral, psychological, and 
emotional variables that accompany living with diabetes.  Self- management is a critical 
component of controlling diabetes.  If patients are unable to communicate difficulties 
interfering with proper diabetes care, the physician may believe the patient is deliberately 
nonadherent (Nam, Chesla, Stotts, Kroon, & Janson, 2011).  Due to the psychological 
and emotional components of diabetes management, the implementation of CBT can 
facilitate a patient’s willingness to persist with their glycemic control.   
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Cognitive Behavioral Therapy for Diabetes 
 Research indicates that less than 50% of patients achieved the recommended 
target of an A1c level less than 7 (Hoerger, Segel, Gregg, & Saaddine, 2008), 
notwithstanding the fact that studies have shown that poor glycemic control heightens 
risk of complications.  This information implies that strict glucose control can be difficult 
for the majority of diabetes patients (Snoek et al., 2001).  An estimated 10-25% of adults 
who present with persistent glycemic control also struggle to adhere to medical 
recommendations (Snoek et al., 2001).  A potential explanation for this positive 
correlation lies in the patient’s beliefs and attitudes regarding health and behavior change.  
For instance, it is common for patients with past difficulty sustaining a consistent 
glycemic index to develop negative attitudes or attributions about their own abilities.  The 
reason for implementing a cognitive behavior therapy (CBT) regimen is to modify 
negative beliefs and attitudes about managing diabetes and related complications (Snoek 
et al., 2001).  Ultimately, the goal of introducing CBT techniques is to increase adherence 
through modifying negative attitudes and beliefs.  The use of a comprehensive approach 
addressing self-care, education, and cognitive restructuring of underlying negative 
attitudes has demonstrated positive effects on adherence (Rubin, Peyrot, & Saudek, 
1989).   
Although research using CBT to directly target diabetes is scarce, a study using a 
Cognitive Behavioral Groups Training (CBGT) was implemented in a Type 1 diabetes 
population.  The sample consisted of individuals who were identified as having 
significant difficulty managing their HbA1c.  The focus of the group was on cognitive 
restructuring, in which patients were encouraged to identify and challenge inaccurate 
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beliefs.  In this study, four topics were addressed in the groups: the cognitive-behavioral 
model of diabetes; stress and diabetes; worry about diabetes complications; social 
relationships (Snoek et al., 2001).  Consistent with CBT, weekly homework was assigned 
at the end of each session.  Results of the study showed a 0.8% decrease in HbA1c and 
were considered important because of the challenging patients used in the study.  The use 
of CBT allowed for additional behavioral support while also modifying or restructuring 
any existing negative beliefs or attitudes associated with diabetes management.   
CBT for Diabetes-Related Depression and Adherence 
 Individuals with diabetes are twice as likely to suffer from depression compared 
to the general population (ADA, 2011).  Depressive episodes are also more likely to recur 
and be more severe in diabetic patients. Depression is a major factor affecting a patient’s 
ability to adhere to their physician’s recommendations (ADA, 2011).  In consequence, 
depression in diabetes patients has been linked to poorer glycemic control, nonadherence, 
and mortality (Gonzalez et al., 2008).  In order for effective diabetes treatment to take 
place, the identification and treatment of possible depressive symptoms are vital.  
Compared to nondepressed diabetes patients, depressed patients are at an increased risk 
of experiencing functional impairments in their ability to manage their illness (Katon & 
Sullivan, 1990; Lustman, Clause, & Carney, 1989).   
An additional study was designed to measure the treatment effect of Cognitive 
Behavioral Therapy for Adherence and Depression (CBT-AD) on adherence, depression, 
and HbA1c.  CBT-AD consisted of an introduction to CBT, increasing pleasurable 
activities and monitoring mood, monitoring thoughts and cognitive restructuring, 
problem-solving skills particularly related to diabetes, and relaxation training (Safren et 
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al., 2013).  Following completion of four months of CBT-AD, diabetes patients with 
comorbid depression improved their adherence to medication by 21%, and were 30% 
more likely to adhere to a medication regimen than patients who received a normal 
course of treatment. The goal of the Shared Medical Appointment (SMA) is achieving a 
higher level of integrated care used to promote positive self-care and improve adherence 
by diabetic patients. 
Shared Medical Appointment 
 The Shared Medical Appointment is an increasingly important practice in the field of 
behavioral health.  The Shared Medical Appointment (SMA) was developed to provide 
patients with a more expansive and flexible model to assist with managing the 
complexity of diabetes (Kirsch et al., 2007).  Its development stemmed from Wagner’s 
Chronic Care Model (1998), which placed emphasis on identifying patients at the highest 
risk for complications.  The development of the SMA was also facilitated by a lack of 
access on the part of the patient to integrated behavioral health care.  A shared medical 
appointment addressed multiple needs of the patient and also  enhanced physicians’ 
productivity (Bronson & Maxwell, 2004).  The goal of the SMA is to provide necessary 
support and patient education that may be lacking in a traditional visit to the doctor.  
Shared medical appointments are also designed to facilitate necessary follow-up visits.   
  The structure of the SMA includes a series of one-on-one encounters with a 
physician and behavioral health specialist (Bronson & Maxwell, 2004).  The SMA 
typically takes between 60 and 120 minutes and includes eight to 20 patients (Kirsch et 
al., 2007).  The first phase is a group visit with the physician and the behavioral health 
specialist; the second phase involves bringing participants into a group, which shares 
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psychoeducation information (Bronson & Maxwell, 2004; Kirsch et al., 2007).  During 
the SMA, the physician and behavioral health care specialist play distinct roles.  The 
physician’s role is to evaluate, examine and treat patients in a fashion similar to a typical 
doctor visit; he or she also assumes responsibility for documenting the patient’s medical 
history (Bronson & Maxwell, 2004).  Behavioral specialists provide informed consent 
and maintain the confidentiality of patient information, and engage in discussion with the 
patient while the physician performs other roles, providing appropriate referrals if 
necessary, and ensuring that the patient receives adequate time to address their questions 
and concerns (Bronson & Maxwell, 2004).  A SMA entails a higher level of integration 
among health care professionals, meaning that information is routinely exchanged 
between them.  The SMA provides patients with the highest level of integrated care, 
because they receive treatment from multiple providers who address different treatment 
issues.  The necessary interventions are separate yet connected, in that they address 
different obstacles faced by the patient.  Patient satisfaction, as well as the effectiveness 
of treatment, has improved in patients who have participated in an SMA (Wagner et al., 
2001).   
A study by Wagner et al. (2001) was conducted with a population of Type 2 
diabetes patients who were randomly assigned to physician-only treatment or a shared 
visit.  Results indicated that diabetic patients who received group treatment over a two-
year period had fewer visits to the emergency room, fewer disability days, and more 
improvement in their health status (Wagner et al., 2001).  Another randomized study 
involving individuals with Type 2 diabetes patients took place over a four-year period to 
determine the utility of an SMA as measured by HbA1c and weight loss (Trento et al., 
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2002).  Prior to treatment, individuals in the study had a mean HbA1c of 7.4 at baseline.  
Participants in the shared medical appointment had an average decrease to 7.0, but 
individuals receiving standard treatment experienced a rise in  average HbA1c level to 
8.6 (Trento et al., 2002).  Diabetic patients in the shared visit group lost an average of 2.6 
k.g., compared to an average loss of 0.9 k.g. in the control group (Trento et al., 2002).   
Patients participating in an SMA are more likely to experience a higher level of 
patient satisfaction.  Following the SMA, 85% of patients requested another shared group 
visit for their next appointment (Bronson & Maxwell, 2004).  In the same group, 79% of 
the patients rated their experience of participating in an SMA as excellent (Bronson & 
Maxwell, 2004).  This result indicates that although individuals spent less time with a 
physician during an SMA, patients were able to obtain knowledge and skills through 
interacting with other individuals experiencing a similar health problem.  A developing 
camaraderie potentially enabled patients to create a network of social support outside of 
their physician’s office.  Individuals also reported a sense of accountability to follow up 
with recommended treatment due to the group dynamic.   
A potential pitfall of an SMA is a low turnout.  A low turnout may make the SMA 
costlier and less efficient than a standard physician-only appointment (Bronson & 
Maxwell, 2004).  Patients may be unfamiliar with this format and consequently opt not to 
participate (Bartley, & Haney, 2010).  Another potential difficulty that accompanies 
orchestrating a successful SMA lies in creating a comfortable learning atmosphere for the 
patients.  One factor that limited the effectiveness of the SMA was physicians or 
behavioral specialists who treated it like a class.  The group sessions are more effective 
when they are executed similarly to a medical encounter rather than lecturing patients on 
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proper care (Bronson & Maxwell, 2004).  It is also important to consider that not all 
patients are appropriate SMA participants.  Examples include individuals who will not 
maintain confidentiality, who are hearing or cognitively impaired, or who require an 
interpreter (Bronson & Maxwell, 2004).   
 Motivation to Change 
 Motivational interviewing (MI) is a core component of the SMA.  MI has been 
defined as “a collaborative conversation style for strengthening a person’s own 
motivation and commitment to change” (Miller & Rollnick, 2013, p.  12).  It is a client-
centered intervention that aims to change behavior through an exploration of the patient’s 
motivation to change (Miller & Rollnick, 2013).  The use of motivational interviewing in 
an integrated care setting can be an integral part of treatment, because it challenges 
health-care professionals to resist what Miller & Rollnick have termed the “righting 
reflex” (2013, p.  9).  The righting reflex is the “belief that you must convince or 
persuade the person to do the right thing” (Miller & Rollnick, 2013, p.  11).  In order to 
resist this urge, physicians are encouraged to step aside from the role of the fixer, instead 
focusing on how to create the best course of action for a particular patient (Miller & 
Rollnick, 2013).   
The use of MI to enhance behavioral change in patients with a chronic medical 
condition, such as diabetes, is often counteracted by a certain degree of ambivalence.  
Ambivalence arises when individuals are aware of a necessary behavioral change but are 
unsure about their need to implement it (Miller & Rollnick, 2013).  In order to work 
through ambivalence, Miller and Rollick (2013, pg.  10) assert the need to evoke “change 
talk” from the patient.  Change talk describes a patient’s ability to use their own 
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motivational statements about why change is important to enable a necessary behavioral 
change (Miller & Rollnick, 2013).  The premise of change talk is important, because 
hearing oneself present reasons for change increases the likelihood of performing the 
associated behaviors (Miller & Rollnick, 2013).   
Miller and Rollnick (2013) posited partnership, acceptance, compassion, and 
evocation as four vital components of MI.  The first component, partnership, emphasizes 
the fact that the patient and physician are both considered as experts in treating the 
chronic condition (Miller & Rollnick, 2013).  The physician has expertise in medical 
knowledge and practice, but the patient is the expert on their own body.  It requires 
forming an active collaboration, with the goal of avoiding coercion and creating an 
environment conducive to change (Miller & Rollnick, 2013).  Acceptance of what the 
client brings is the second vital component of MI (Miller & Rollnick, 2013, p.  15).  In 
the MI framework, acceptance has four principles: absolute worth, accurate empathy, 
autonomy support, and affirmation (Miller & Rollnick, 2013).  Compassion is the third 
component.  In MI, compassion differs from its typical definition; it does not focus on 
feelings or emotions and should not be confused with sympathy.  Instead, it describes the 
prioritization of the patient’s needs and overall welfare (Miller & Rollnick, 2013).  
Evocation is the final component of MI.  According to Miller and Rollnick (2013, p.  17), 
the message of evocation to the patient is “You have what you need, and together we will 
find it”.  This sends the message to patients that each possesses personal strengths and 
skills that will be utilized effectively in making a positive behavioral change (Miller & 
Rollnick, 2013).   
INTEGRATED PRIMARY CARE  30  2 
 
 
Due to the complexity of managing diabetes, MI has been applied as a 
supplemental treatment to enhance adherence in patients.  The literature indicates that MI 
should be utilized in combination with other front-line treatments to manage chronic 
illness, because it emphasizes patient-centered care and positive affects on the patient-
physician relationship (Anstiss, 2009).  When MI was implemented with individuals with 
diabetes, evidence indicated that patients obtained greater knowledge and understanding 
of diabetes, a more accurate perception of diabetes and one’s ability to manage it, as well 
as increased motivation to make behavioral changes (Rubak, Sandbaek, Lauritzen, 
Borsch-Johnson, & Christensen, 2009).  MI has also been linked to improvements in 
weight loss, BMI, and HbA1c in a population of participants with diabetes (West, 
DiLullo, Bursac, Gore, & Greene, 2007).  Further research indicated the efficacy of MI in 
targeted glycemic control.  In a population of individuals with Type 1 diabetes, MI 
contributed to long-term improvement in glycemic control, quality of life, and self-
reported overall psychological wellbeing (Channon et al., 2007).  Improvements in 
glycemic control significantly reduce the likelihood of developing or exacerbating the 
severe co-occurring conditions associated with poorly managed diabetes.   
Behavioral Health Target Variables 
Body- Mass Index (BMI) 
 During the 1970s, Body Mass Index (BMI) emerged through the application of a 
mathematical construct in which weight is a quadratic function of height (Muller, 2016).  
BMI  soon gained favor as a measure preferable to relative weight.  Three main points in 
the current literature support the utility of BMI: Weight is not a linear function of an 
individual’s height, therefore BMI uses a formula consistent with research indicating that 
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increases in weight are proportionate to height squared; BMI does not depend on one’s 
stature; research on BMI has demonstrated its correlation with fat mass (Muller, 2016).   
As the number of individuals in the population diagnosed with diabetes increased, 
it coincided with an increase in specific risk factors.  Obesity and being overweight are 
two of the most significant but modifiable risk factors associated with diabetes.  Research 
over the past 30 years has demonstrated that adult obesity has risen, which coincided with 
a 33% increase in diabetes diagnoses from 1988 to 1994 and 2005 to 2010 (Menke, Rust, 
Fradkin, Cheng, & Cowie, 2014).   
In terms of BMI, adult obesity is defined as being equal to or greater than 30 
kg/m2.  National surveys were conducted from 1988 to 2010 using BMI to measure 
classification of adults’ weight.  From 1988 to 1994, 22.3% of the population surveyed 
was classified as obese.  This percentage rose to 30.5% from 2000 to 2002, and to 35.9% 
from 2009 to 2010 (Menke, Rust, Fradkin, Cheng, & Cowie, 2014).  These results were 
the basis of a study that examined the connection between the rising diabetes rate and the 
increase in obesity as measured by BMI.  The study’s results indicated that diabetes risk 
increased concurrently with obesity in the United States, and that BMI was the most 
prominent risk factor in the onset of Type 2 diabetes (Menke, Rust, Fradkin, Cheng, & 
Cowie, 2014).  In contrast, successful weight management through lifestyle change 
significantly improved outcomes in diabetes patients.   
Throughout the literature, evidence associated increased physical activity for 
approximately 30 minutes per day with a decreased risk of developing Type 2 diabetes 
(Hu et al., 2004).  Further research has examined the relationship between the amount of 
physical activity, BMI, and an individual’s ability to successfully manage their blood 
INTEGRATED PRIMARY CARE  32  2 
 
 
glucose (Hu et al., 2004).  Individuals who participated in the study met the BMI criteria 
for obesity (BMI  >  30).  The participants then self-reported their level of physical 
activity (light, moderate, or active) and recorded the amount of time one spent partaking 
in the activity (low, moderate, or high).  The outcome measure for these individuals was 
blood glucose.  The results of the study indicated that individuals who had more 
impairment in their ability to regulate glucose were more likely to be from lower 
educational backgrounds, have higher mean values of BMI and high blood pressure, and 
to be obese (Hu et al., 2004).  In addition, reduction in BMI and a moderate level of 
physical activity proved to be protective factors against the development of Type 2 
diabetes (Hu et al., 2004).   
Blood Pressure/ Hypertension 
Diabetes is a significant independent factor contributing to the development of 
cardiovascular disease (ADA, 2011).  High blood pressure also negatively impacts 
various parts of the body and increases an individual’s risk of developing additional 
complications (ADA, 2011).  Research indicates that up to 70% of deaths in diabetes 
patients are attributable to cardiovascular ailments (Choma, Griffin, Kaltenbach, Greevy, 
& Roumie, 2011).  Another 70% of individuals with diabetes also have hypertension or 
are actively managing high blood pressure with medication (ADA, 2011).  Moreover, 
hypertension in a diabetic patient is especially threatening due to its connection with 
diabetic neuropathy, which is developed by approximately 20-30% of diabetic patients 
(Banach, Aronow, Serban, Rysz, Voroneanu, & Covic, 2015).   
When hypertension develops, blood in the body flows at an increased rate, forcing 
the heart to work harder (ADA, 2011).  More stress is placed on the heart, resulting in 
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arterial damage and the production of a fatty tissue known as atheroma (ADA,2011).  
The formation of atheroma results from the arteries becoming narrow or blocked 
completely, resulting in a reduction of blood flow (ADA, 2011).  When this occurs, an 
individual becomes more susceptible to heart attack, stroke, and other complications.   
When an individual is diagnosed with diabetes, they face new challenges, 
including strict blood pressure management.  Individuals with high blood pressure and 
diabetes are 4 times more likely to die compared to individuals who have neither of these 
conditions (ADA, 2011).  Previous research has identified risk factors, such as baseline 
uncontrolled blood pressure, required use of oral medication, as opposed to insulin or diet 
and exercise, and prescription of three or more medications to control blood pressure.   
A study was conducted in a population of veterans to examine blood pressure 
control in individuals newly diagnosed with diabetes (Choma, Griffin, Kaltenbach, 
Greevy, & Roumie, 2011).  The aim of the study was to determine one’s ability to 
successfully control blood pressure in the first two years after diagnosis.  Participant’s 
blood pressure was measured at baseline and in 6-month increments, until the 2-year 
threshold had been reached.  In accordance with the American Diabetes Association 
recommendation for blood pressure, the target goal was <130/80 mmHg (ADA, 2010).  
Results indicated that approximately 65% of the participants met the ADA standard for 
blood pressure control after 6 months and at the 2-year follow-up (Choma, Griffin, 
Kaltenbach, Greevy, & Roumie, 2011).  After the 6-month measurement, however, no 
further improvements were observed.  Several explanations were proposed, including 
medication adherence, the effort of the patient or their physician, and a sedentary lifestyle 
(Choma, Griffin, Kaltenbach, Greevy, & Roumie, 2011).   
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Cholesterol 
Cholesterol is “a fatty substance that is an essential component of cell membranes 
and is used by the body for insulating nerve fibers” (Metzenger & AMA, 2006, p. 94). 
There are two main types of cholesterol, high-density lipoprotein (HDL) cholesterol and 
low-density lipoprotein (LDL).  HDL cholesterol is often referred to as good cholesterol, 
while LDL is dubbed bad cholesterol.  High levels of LDL cholesterol result in fatty 
build-ups in the arteries (Metzenger & AMA, 2006).  HDL cholesterol is responsible for 
helping to clear these fatty deposits, which is why having a good ratio between HDL and 
LDL is beneficial (Metzenger, & AMA 2006).  The measurement of fat that stores energy 
released between meals to fuel the body is termed triglycerides (Metzenger & AMA, 
2006).  The recommended target levels for each type of cholesterol are as follows: LDL 
cholesterol below 100 mg/dl, HDL cholesterol above 40 mg/dl for men and above 50 
mg/dl for women, and triglyceride level below 150 mg/dl (ADA, 2011).  When 
cholesterol levels do not meet the recommended standards, significant complications 
arise.   
The vast majority of cardiac complications in diabetic patients are caused by a 
reduction of blood flow in the arteries caused by a blockage.  Individuals with diabetes 
are already considered to be at higher risk of developing narrow blood vessels.  High 
cholesterol is another factor that greatly increases a diabetic patient’s likelihood of 
experiencing cardiovascular problems (ADA, 2011).  High cholesterol and triglycerides 
contribute significantly to the hardening of the arteries.  As the arteries harden and 
function less efficiently, blood builds up along the walls of the blood vessels (ADA, 
2011).   
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Hemoglobin A1c (HbA1c) 
The initial onset of diabetes occurs when either the body is unable to make 
enough insulin or it misuses insulin that is produced.  In either instance, glucose in the 
body is unable to make its way into various cells in the body.  Instead, blood glucose 
levels become too high, because glucose remains in the blood (Reddy, 2009).  It is also 
common for the excess glucose remaining in the body to cause weight gain as well as 
damage blood vessels and nerves (ADA, 2009).  Glucose is perhaps the most important 
term to understand in diabetes management.  It is also commonly referred to as blood 
sugar and mainly enters the body in the form of carbohydrates (ADA, 2009).   
 Hemoglobin A1c is a test used to measure blood glucose levels over a 3-month 
period in an individual with diabetes (Reddy, 2009).  More specifically, the 
concentrations of hemoglobin molecules that have glucose attached to them are measured 
as a percentage (ADA, 2011).  An individual without diabetes typically has hemoglobin 
A1c levels within the range of 4% to 6% (Reddy, 2009).  In the diabetes population, the 
goal for hemoglobin A1c is < 6.5% (Reddy, 2009).  In order to reduce or change blood 
glucose levels, the ADA (2011) recommends reducing food consumption, altering the 
types of food consumed, increasing physical activity, and the alteration of insulin levels 
by a medical professional.  Years of accumulated research has indicated the importance 
of successfully regulating blood glucose levels.   
 Two landmark studies showed the importance of glucose control and its 
relationship with the prevention of diabetes or reduction in the risks associated with 
diabetes: The Diabetes Control and Complications Trial (DCCT) and the United 
Kingdom Prospective Diabetes Study (UKPDS).  The DCCT was conducted over a ten-
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year span from 1983-1993 in the United States and Canada.  The inclusion criteria 
required having Type 1 diabetes for at least 1 year but less than 15 years.  A group of 
1,441 individuals who met the criteria participated in the study.  The aim of the DCCT 
was to determine whether standard blood glucose management was sufficient to reduce 
diabetes-related complications or if treatment required a more intensive approach 
(Lasker, 1993).  For the purpose of the study, individuals in the intensive glucose control 
group were given the goal of maintaining A1c levels at <  6%, as opposed to  <  6.5%. 
and were given either an insulin pump or multiple injections daily, as compared to 
individuals who received only 1-2 insulin injections (NIH, 2008; ADA, 2011).  The study 
examined three major complications: eye disease, kidney disease, and cardiovascular 
disease (NIH, 2008).  The results on the DCCT revealed that individuals receiving the 
more intensive treatment regimen had a 76% reduction in the risk of developing diabetic 
retinopathy, a 54% reduction in the progression of diabetic retinopathy in individuals 
with early signs of the disease, a 50% risk reduction for kidney disease, a 60% reduction 
in the development of nerve damage, and a 35% reduction in cholesterol levels (ADA, 
2001; Lasker, 1993; NIH, 2008). 
 The UKPDS had a sample of 5,102 individuals who were recently diagnosed with 
Type 2 diabetes (ADA, 2011; King, Peacock, & Donnelly, 1999).  The study aimed to 
build on the results of the DCCT study, which examined only Type 1 diabetes.  The 
study’s goal was to answer several questions and concerns related to diabetes 
management, including whether intensive blood pressure control affected complications, 
whether an individual’s quality of life was affected by intensive blood glucose control, 
and cost-effectiveness of intensive blood glucose control (King, Peacock, & Donnelly, 
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1999).  Results of the UKPDS indicated that individuals who received intensive 
intervention targeting blood glucose levels experienced a 25% reduction of risk of 
microvascular complications (eyes and nerve disease), a 44% reduction of risk of stroke, 
a 56% reduction of  risk of heart failure, and reduction of risk for heart attack and 
mortality from a diabetes-related complication (ADA, 2011; King, Peacock, & Donnelly, 
1999).  
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Chapter 2: Research Question 
Does a higher level of integrated care (SMA) produce better diabetes treatment outcome 
than lower levels of integrated care, such as BHC plus IPC and IPC as measured by A1c 
change, blood pressure change, BMI change, and LDL change? 
Hypothesis 1 
Individuals with diabetes who received the highest level of integrated care in the form of 
IPC plus shared medical appointment will show significantly more improvement in 
measures of BMI, as compared to IPC plus cognitive behavioral therapy.  Each combined 
treatment regimen will show more significant improvement than IPC alone.   
Hypothesis 2 
Individuals with diabetes who received the highest level of integrated care in the form of 
IPC plus shared medical appointment will show significantly more improvement in 
measures of systolic blood pressure, as compared to IPC plus cognitive behavioral 
therapy.  Each combined treatment regimen will show more significant improvement than 
IPC alone.   
Hypothesis 3  
 Individuals with diabetes who received the highest level of integrated care in the form of 
IPC plus shared medical appointment will show significantly more improvement in 
measures of diastolic blood pressure, as compared to IPC plus cognitive behavioral 
therapy.  Each combined treatment regimen will show more significant improvement than 
IPC alone.   
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Hypothesis 4 
Individuals with diabetes who received the highest level of integrated care in the form of 
IPC plus shared medical appointment will show significantly more improvement in 
measures of hemoglobin A1c, as compared to IPC plus cognitive behavioral therapy.  
Each combined treatment regimen will each show more significant improvement than 
IPC alone.   
Hypothesis 5 
 Individuals with diabetes who received the highest level of integrated care in the form of 
IPC plus shared medical appointment will show significantly more improvement in 
measures of HDL, as compared to IPC plus cognitive behavioral therapy.  The two 
combined conditions will each show more significant improvement than IPC alone.   
Hypothesis 6 
 Individuals with diabetes who received the highest level of integrated care in the form of 
IPC plus shared medical appointment will show significantly more improvement in LDL 
compared to IPC plus cognitive behavioral therapy.  Each combined treatment regimen 
will show more significant improvement than IPC alone.   
Hypothesis 7 
Individuals with diabetes who received the highest level of integrated care in the form of 
IPC plus shared medical appointment will show significantly more improvement in a 
measure of total cholesterol, as compared to IPC plus cognitive behavioral therapy. Each 
combined treatment regimen will show more significant improvement than IPC alone.   
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Overall Rationale.  An integrated care approach is consistent with the theory that 
providing individuals with an additional support system will increase their likelihood of 
adhering to medical recommendations.  Improvements in diabetes management have 
been linked to the use of a behavioral health support team, because the psychosocial 
needs of the patient are also met.  Therefore, individuals receiving an additional form of 
treatment combined with IPC are expected to show significant improvement in the 
outcome measures.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTEGRATED PRIMARY CARE  41  2 
 
 
Chapter 3: Methodology  
Design  
This study is a nonrandomized, uncontrolled, naturalistic, cross-sectional 
quantitative evaluation of integrated medical services using archival data from four urban 
health care centers (Roxborough, Lancaster, Cambria & Family Medicine) associated 
with the Philadelphia College of Osteopathic Medicine.  The study examined the 
differences in hemoglobin A1c, blood pressure, body mass index (BMI), and low-density 
lipoprotein (LDL) across treatment conditions.  Comparisons of the outcome measures 
were based on whether individuals participated in a shared medical appointment (SMA), 
behavioral health care (BHC) services (6-8 sessions of cognitive behavioral therapy), or 
integrated primary medical care.  The study pitted integrated medical care and behavioral 
health care conditions against a more fully integrated level of care (including SMA) and 
examined each of these modalities relative to treatment as usual.  Integrated primary care 
was considered treatment as usual. 
Participants 
The participants were selected from Philadelphia College of Osteopathic 
Medicine’s health care facilities.  The health care centers are located throughout various 
underserved locations of Philadelphia; in general, participants’ socioeconomic status was 
low.  Participants were previously recommended for a higher level of care due to an 
inability to manage their diabetes or received medical care as usual from their physician.  
Individuals recommended to a higher level of care participated in one of two conditions: 
1) Shared Medical Appointment (SMA) or 2) behavioral health care (BHC) services.  The 
minimum age for participants was 18.    
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Inclusion criteria 
The subjects participated in one of the treatment intervention conditions and must 
have been diagnosed with Type 1 or Type 2 diabetes that was considered by their medical 
care provider to be poorly managed (i. e., HbA1c > 8). Participants were age 18 or older, 
and were patients at one of PCOM’s health care centers.   They must have received only 
one of three types of care.   
Exclusion criteria 
The exclusion criteria were as follows: under the age of 18; lacking a documented 
diagnosis of diabetes; not a patient sat one of PCOM’s four health care centers; not 
participated in one of the three treatment conditions.   
Measures 
All deidentified data were extracted from the patient’s charts on the NextGen electronic 
medical record by a consultant with the Department of Family Medicine. 
Demographic information Sheet.  Measures included the participant’s age, 
gender, race, and ethnicity.   
Glycated Hemoglobin (HbA1c)  
Glycated hemoglobin develops when hemoglobin, a protein in red blood cells that 
carry oxygen throughout the body, combines with glucose in an individual’s blood.  
HbA1c is often used as a diagnostic test for diabetes.  HbA1c testing provides an overall 
picture of an individual’s average blood sugar levels over a period of weeks or months.  
The sample is measured by a fasting plasma glucose test.  The current recommended 
diagnostic cutoff by the American Diabetes Association (ADA) is an HbA1c < 6.5.  To 
test HbA1c, a medical professional takes a blood sample from the patient’s finger or arm, 
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which is then laboratory-tested.  For the purpose of the study, the most recent HbA1c 
tests will be extracted from the patient’s electronic health record by the investigator.   
Body Mass Index (BMI)   
Individuals who are considered overweight or obese are more likely to develop 
Type 2 diabetes and other medical problems.  Upwards of 75% of individuals living with 
Type 2 diabetes are currently obese or were at one point in time (ADA, 2011).  BMI is 
calculated by dividing weight in pounds by height in inches squared and multiplying by a 
conversion factor of 703 (weight [lb]/height [in]2 x 703).  The physician should calculate 
a patient’s BMI at each visit, and the American Diabetes Association (2011) recommends 
immediate calculation and documentation in the patient’s medical record.  The patient’s 
BMI will be extracted from their chart by the principal investigator.  The patient’s BMI 
following the completion of their level of care will be compared to their BMI prior to 
treatment to determine the effectiveness of the intervention.  BMI classifies an 
individual’s weight into the categories of underweight (below 18.5), normal weight (18.5-
24.9), overweight (25.0-29.9), and obese (30.0 and above).  The development of diabetes 
complicates one’s ability to successfully manage weight.  Individuals who are overweight 
are already more likely to put more pressure on their bodies to function properly (ADA, 
2011).   
Research has indicated that if the weight inside the abdomen is higher than on the 
hips and thighs, cells within the body are likely less sensitive to insulin (Metzenger & 
AMA, 2006).  Insulin production in an overweight individual is more difficult to regulate 
and therefore complicates diabetes management.  The body then becomes resistant to 
insulin, and many overweight individuals require higher doses.  The ADA recommends 
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that individuals with a BMI over 25 kg/m2 or greater should be considered at risk for 
developing diabetes.  Approaches to improve BMI typically require significant lifestyle 
change, including exercise and reducing daily caloric intake. 
Cholesterol 
 Cholesterol is measured by means of a fasting blood sample, most commonly 
taken from the patient’s arm.  The blood sample is then analyzed in a laboratory.  Once 
the results are received, the data are entered into the patient’s electronic health record.  
The investigator of this study extracted these deidentified data to compare the effect of 
several interventions on a patient’s cholesterol levels.  High LDL cholesterol has been 
linked to an increased risk of coronary heart disease (CHD), to which individuals with 
diabetes are already more susceptible.  Lowering an individual’s LDL cholesterol has 
been shown to reduce the risk of developing CHD.  The ADA recommendation for LDL 
cholesterol is < 100 mg/dl, although a lower guideline of LDL < 70 mg/dl has been 
proposed.  The calculated LDL is a formulation using measurements of total cholesterol, 
HDL cholesterol, and triglycerides. In contrast, high HDL cholesterol is associated with 
lower risk of CHD.  In males, an HDL cholesterol < 40 is considered a risk for CHD and 
in females < 50.  The most common type of fat in the human body are triglycerides.  A 
high triglyceride level of 150 or more is correlated with increased risk of developing 
heart disease or stroke.   
Blood Pressure 
  Blood pressure is measured by a medical health professional during each routine 
diabetes visit.  Their physician then immediately enters the patient’s blood pressure into 
their electronic health record.  For the purpose of this study, the investigator will extract 
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and record the blood pressure of patients who met inclusion criteria for the study  
According to the ADA, individuals who have hypertension, defined as blood pressure of 
140/90 mm Hg or greater, are at a significantly heightened risk of developing diabetes.  
Blood pressure is measured using two inputs, the systolic and the diastolic.  Systolic 
blood pressure represents the pressure in blood vessels when the heart is beating.  
Diastolic blood pressure represents the pressure in blood vessels between each heartbeat.   
Procedure 
The current study was conducted using archival records from the NextGen patient 
database of PCOM’s health care centers.  NextGen is an electronic medical health record 
used by physicians to document patient’s progress on physician-measured variables, as 
well as laboratory tests results.  The NextGen system allows seamless treatment from 
multiple medical and behavioral health professions.  NextGen enables various health care 
providers to identify patients and view their complete treatment history.  In consequence, 
NextGen promotes the use of integrated care for treatment of individuals who present 
with multiple medical conditions.  The NextGen electronic health record improves patient 
engagement and health outcomes and promotes continuity of care.  Data retrieval was 
archival; the data were originally collected by physicians and behavioral health 
professionals at the health care centers.  From the health record, the investigator 
identified patients meeting inclusion criteria and recorded the level of care received by 
each patient (IPC, IPC + SMA, IPC + BHC) and corresponding outcome measures (i.e.,  
HbA1c, BMI, blood pressure, cholesterol).  The archival data were then deidentified by a 
professional staff consultant of the Department of Family Medicine, and only the 
aforementioned categories of information were extracted and entered into an SPSS 24 
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database.  Deidentification entailed the removal of direct patient identifiers, including 
names, medical record numbers, social security numbers, the location of services 
received, and telephone numbers.  Their patient identifiers were replaced with randomly 
generated but valid numbers.  The data were analyzed to identify differences in outcome 
measures based on the level of treatment in which the patient participated.  Participant 
data pertaining to one of three different treatment conditions (IPC, SMA, BHC) on seven 
measures (BMI, systolic blood pressure, diastolic blood pressure, HbA1c, LDL 
cholesterol, HDL cholesterol, and total cholesterol) were evaluated to determine if a 
higher level of care was associated with more successful diabetes management.  The 
principal investigator, with the aid the Chairman of the Department of Family Medicine, 
identified patients meeting the criteria for inclusion who had received one of the three 
treatments, as well as any individuals who received a combination of these treatments. 
Too few such patients existed to warrant analysis.  The data were coded into an SPSS 
database to include age, gender, and ethnicity.   
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Chapter 4: Results 
 
Descriptive Statistics 
To investigate the effect of integrated primary care (IPC) and IPC combined with 
participation in shared medical appointments and behavioral health care about diabetes 
management, a sample of archival patient data originally collected at the various 
Philadelphia College of Osteopathic Medicine health care centers was extracted from the 
NexGen database.  A total of 474 patients’ data met criteria for elevated hemoglobin A1c 
> 8 upon entry into the study.  The total of patients receiving only IPC was highly 
disproportionate to the numbers in the other conditions.  Rather than opting to retain an 
extremely disproportionate number of participants in the first treatment condition, a 
random sample of 40 participants was selected to represent the larger group and 
compared to individuals who received one of the other treatment conditions.  After doing 
so, the study’s total sample size fell to 126.  Frequency distributions for age, gender, race, 
and ethnicity are shown in Table 1.  A total of 55 were male (45.8%), and 63 were female 
(52.5%).  Participant ages ranged from 25-85 years; the mean age was 57.25 years old, 
with a standard deviation of 11.2.  Markedly fewer patients fell into the youngest 
category, and the overwhelming majority fell in the range of 41-85.  In regard to race, the 
majority of the participants indicated that they were African American, with only 7 
(5.8%) identifying as White/Caucasian.  In regard to ethnicity, the majority reported that 
they were Non-Hispanic, with very few participants endorsing the other categories. 
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Table 1.  
Participant Demographic Information 
Characteristic n % 
Gender   
Male  55 45.8 
  Female 63 52.5 
 
Age 
  
18-29 2 1.6 
30-40 6 4.8 
40-85 118 93.7 
Race   
African American 110 91.7 
White/Caucasian 7 5.8 
Unknown 1 .8 
Ethnicity   
Declined to Specify 3 2.5 
Non-Hispanic 112 93.3 
Hispanic or Latino  2 1.7 
Unknown 1 .8 
 
 
 
 
 
 
INTEGRATED PRIMARY CARE  49  2 
 
 
Each patient’s outcome measures were reported in accord with the treatment 
condition they received, as reported in Table 2.  Treatment condition 1 comprised 40 
patients (33%), who received integrated primary care only; treatment condition 2 
comprised 36 patients (30%), who received integrated primary care and participated in at 
least one shared medical appointment; condition 3 comprised 42 patients (35%), who 
received integrated primary care and cognitive behavioral therapy with a behavioral 
health specialist.   
Table 2. 
 
Treatment Conditions 
  Frequency Percent Valid 
Percent 
Cumulative 
Percent 
 
 Condition 1 40 33.3 33.9 33.9  
 Condition 2 36 30.0 30.5 64.4  
 Condition 3 42 35.0 35.6 100.0  
 Total 118 100.0 100.0   
 
Pretest and posttest scores on dependent variables  
As shown in Table 3, the scores of the participants on all measures at pretest are 
provided.  BMIs ranged from18.95 to 55.61, with a mean of 34.14 and standard deviation 
of 7.14.  Systolic blood pressure ranged from 95 to 204, with a mean of 133.45 and 
standard deviation of 19.52.  Diastolic blood pressure ranged from 61 to 120, with a mean 
of 80.78 and standard deviation of 11.01.  Hemoglobin A1c ranged from 6.8 to 16.4, with 
a mean of 10.53 and standard deviation of 2.14.  Hdl cholesterol ranged from 14 to 133, 
with a mean of 49.00 and standard deviation of 16.36.  Ldl cholesterol ranged from 53 to 
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206, with a mean of 110.64 and standard deviation of 37.15.  Total cholesterol ranged 
from 108 to 376 with a mean of 192.47 and standard deviation of 50.0 
 
Table 3.  
Ranges, Means and Standard Deviations for Pretest Variables  
Variable Range Mean Standard Deviation 
BMI 18.95-55.61 34.14 7.14 
Systolic Blood Pressure 95-204 133.45 19.52 
Diastolic Blood Pressure 61-120 80.78 11.01 
Hemoglobin A1c 6.8-46.4 10.53 2.14 
HDL Cholesterol 14-133 49.00 16.36 
LDL Cholesterol 53-206 110.64 37.15 
Total Cholesterol 108-376 192.7 50.02 
 
In Table 4, the scores of the participants on all measures at posttest are presented.  
On the posttests measures, BMI ranged from 21 to 59, with a mean of 34.66 and standard 
deviation of 7.71.  Systolic blood pressure ranged from 86 to 110, with a mean of 132.31 
and standard deviation of 19.48.  Diastolic blood pressure ranged from 54 to 110, with a 
mean of 78.62 and standard deviation of 10.33.  Hemoglobin A1c ranged from 6 to 15, 
with a mean of 9.17 and standard deviation of 2.28.  Hdl cholesterol ranged from 26 to 
76, with a mean of 47.27 and standard deviation of 11.83.  Ldl cholesterol ranged from 
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16 to 195, with a mean of 96.37 and standard deviation of 34.94.  Total cholesterol 
ranged from 109 to 317, with a mean of 171.49 and standard deviation of 41.12. 
Table 4  
Ranges, Means and Standard Deviations for Posttest Variables  
Variable Range Mean Standard Deviation 
BMI 21-59 34.66 7.71 
Systolic Blood Pressure 86-110 132.31 19.48 
Diastolic Blood Pressure 54-110 78.62 10.33 
Hemoglobin A1c 6-15 9.17 2.28 
HDL Cholesterol 26-76 47.27 11.83 
LDL Cholesterol 16-195 96.37 34.94 
Total Cholesterol 109-317 171.49 41.12 
Hypothesis 1:  BMI   
The first hypothesis predicted that individuals with diabetes who received the 
highest level of integrated care in the form of integrated primary care (IPC) and a shared 
medical appointment will show significantly more improvement in measures of BMI 
compared to individuals receiving the behavioral health intervention.  These two 
conditions were predicted to show significantly more improvement than integrated 
primary care.  To test this hypothesis, the current study’s author conducted a 3 x 2 
analysis of variance with repeated measures of one factor.  The independent variables 
were the type of treatment (IPC, IPC plus SMA, and IPC plus behavioral health) and time 
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(pretest to posttest).  BMI was the dependent variable.  The analysis revealed that Box’s 
test, which tests the null hypothesis that the observed covariance matrices of the 
dependent variables are equal across groups, was not significant: Box’s M = 3.15,  
F(6,227501) = .510, p = .801.  Test of within-subjects effect demonstrated a 
nonsignificant change from pretest to posttest: F(1,104) = .576, p =.450; partial eta 
squared = .006.  Levine’s test of equality of error variance on each dependent variable 
was not significant.  On the test of between-subjects effects, a significant effect for 
treatment condition emerged: F(2,104) = 3.603, p = .031, eta squared = .065.  Post hoc 
Tukey analysis revealed a significant difference between treatment condition 1 (IPC) and 
2 (IPC plus SMA): p = .024, with IPC plus SMA having a significantly higher BMI.  No 
other comparisons were significant.   
Hypothesis 2: Systolic Blood Pressure 
For this hypothesis, a 3 x 2 ANOVA with repeated measures on one factor was 
conducted on the dependent variable of systolic blood pressure.  The analysis revealed 
that Box’s test, which tests the null hypothesis that the observed covariance matrices of 
the dependent variables are equal across groups, was not significant: Box’s M = 8.66, 
F(6,255619) = 1.405, p = .208.  Partial eta squared was equal to .018.  The test of within-
subjects effects demonstrated a nonsignificant change from pretest to posttest F(1,109) = 
1.96, p = .16, partial eta squared = .018, a small effect.  Levine’s test of equality of error 
variances on each dependent variable was not significant for the posttest blood pressures 
but differed on the pretests.  The test of the between-subjects effect revealed no 
significant effect for treatment condition: F(2,109) = .022, p = .978, eta squared = .000. 
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Hypothesis 3:  Diastolic Blood Pressure 
To test this hypothesis, a 3 x 2 ANOVA with repeated measures on one factor was 
conducted on the dependent variable of diastolic blood pressure.  The analysis revealed 
that Box’s test, which tests the null hypothesis that the observed covariance matrices of 
the dependent variables are equal across groups, was not significant: Box’s M = 3.56, 
F(6,255619) = .578, p =         .748).  The test of within-subjects effects demonstrated a 
significant change from pretest to posttest: F(1,109) = 5.527, p = .02; partial eta squared 
= .048, a small effect.  Levine’s test of equality of error variance on the pretest and 
posttest was not significant.  The test of the between-subjects effects revealed no 
significant effect for treatment condition: F(2,109) = 1.11, p = 332, partial eta squared = 
.02. 
Hypothesis 4:  Hemoglobin A1c 
A 3 x 2 ANOVA was conducted to evaluate the potential impact of treatment 
across time for hemoglobin A1c.  The analysis revealed that Box’s test, which tests the 
null hypothesis that the observed covariance matrices of the dependent variables are 
equal across groups, was not significant: Box’s M = 6.188,  F(6,207186.20) = 1.00,  p = 
.423.  The test of within-subjects effect demonstrated a significant change from pretest to 
posttest: F(1,96) = 27.39, p =.000, partial eta squared = .222.  Levine’s test of equality of 
error variance on the pretest and posttest were not significant.  The test of the between-
subjects effect revealed no significant effect for treatment condition: F(2,96) = .405, p = 
668; eta squared = .008. 
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Hypothesis 5:  HDL Cholesterol 
The dependent variable for this analysis was HDL cholesterol.  The analysis 
revealed that Box’s test, which tests the null hypothesis that the observed covariance 
matrices of the dependent variables are equal across groups, was not significant: Box’s M 
= 9.608, F(6,78660.07) = 1.521, p = .167.  The test of within-subjects effect demonstrated 
no significant change from pretest to posttest: F(1,58) = 1.468, p = .23,  partial eta 
squared = .025.  Levine’s test of equality of error variance on the pretest and posttest was 
not significant.  Test of the between-subjects effect revealed no significant effect for 
treatment condition: F(2,58) = 1.127, p = 331, eta squared = .037  
Hypothesis 6:  LDL 
The dependent variable for this 3 x 2 ANOVA with a repeated measure on one 
factor was LDL cholesterol.  The analysis revealed that Box’s test, which tests the null 
hypothesis that the observed covariance matrices of the dependent variables are equal 
across groups, was not significant: Box’s M = 7.284, F(6,76853.38) = 1.151, p = .329).  
The test of within-subjects effect demonstrates a significant change from pretest to 
posttest: F(1,56) = 5.527, p = .022, partial eta squared = .090.  Levine’s test of equality of 
error variance on each dependent variable was not significant.  The test of the between-
subjects effect revealed no significant effect for treatment condition: F(2,56) = .490,  p = 
.615, eta squared = .017.   
Hypothesis 7:  Total Cholesterol 
The dependent variable for this analysis was total cholesterol.  The analysis 
revealed that Box’s test, which tests the null hypothesis that the observed covariance 
matrices of the dependent variables are equal across groups, was not significant: Box’s M 
INTEGRATED PRIMARY CARE  55  2 
 
 
= 8.865, F(6,78660.07) = 1.375, p = .220.  Test of within-subjects effect demonstrates a 
significant change from pretest to posttest: F(1,58) = 11.61, p = .001, partial eta squared 
= .167.  Levine’s test of equality of error variance on each dependent variable was not 
significant.  The test of the between-subjects effect revealed no significant effect for 
treatment condition: F(2,58) = .00, p = 1.00; eta squared = .00.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTEGRATED PRIMARY CARE  56  2 
 
 
Chapter 5: Discussion 
 
Findings and Clinical Implications  
 
A traditional primary care visit is a one-on-one meeting between a patient and 
clinician.  However, this format may be inappropriate for addressing chronic diseases like 
diabetes, which require complex ongoing treatment (Egger et al., 2014).  The use of an 
integrated primary care model counteracts this problem by allowing health care 
professionals to collaborate with the patient and each other, thus fully addressing the 
multitude of presenting problems related to diabetes (Blount, 2003).  The present study 
was performed to determine whether additional treatment in the form of IPC plus SMA or 
IPC plus behavioral health care, in the form of cognitive behavioral therapy, would 
improve health outcomes in diabetic patients compared to diabetic patients who received 
IPC alone, as measured by 7 outcome variables.  Generally speaking, with the exclusion 
of BMI, when significant changes were observed, the treatment groups did not differ 
significantly in outcome. 
Of the 7 outcome variables, none showed improvement as a result of receiving a 
higher level of care in addition to IPC.  However, 4 of the 7 variables improved over 
time, regardless of treatment condition.  This is an interesting finding, suggesting that 
perhaps the addition of SMA and behavioral health care did nothing beyond what is 
accomplished by IPC alone.  Given the nature of the present evaluation, especially the 
number of uncontrolled variables, many reasons for this finding are possible, and the 
results should not be taken as demonstrating that these treatments may not be effective 
when implemented under more controlled conditions using a standardized treatment 
delivery protocol.  In addition, outcomes that may have been more likely to be affected 
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by SMA and CBT were not available for analysis in this study.  The findings for each 
outcome are discussed below.   
BMI 
 In the single instance in which BMI did not change over time, a treatment 
condition effect obtained; those receiving IPC only did significantly better than IPC plus 
SMA.  Although neither of these treatments provided targeted behavioral treatment for 
weight control, why the IPC group fared better is perplexing.   
This finding may have resulted from the fact that individuals who participate in a 
SMA are generally considered in worse physical condition than the average patients, and 
their diabetes is considered to be “out of control” (Edelman et al., 2012).  At PCOM, 
patients receive a recommendation to participate in a SMA if their hemoglobin A1c is  > 
8.  However, no standardized criterion is in place for referral to the additional treatments.  
Patients who participated in a SMA may have faced more challenges to their lifestyle 
habits than the patients in IPC only.  In the literature, one of the dominant factors 
correlated with high BMI in adulthood is being overweight in adolescence (Goran, 2001).  
Environmental factors that contribute overweight adolescents include an environment in 
which healthy foods were not readily available from a young age, as well as access to 
foods that are inexpensive but have a high caloric content (Cugnetto et al., 2007).  
Considering that PCOM’s health care centers are located in urban areas, and the majority 
of patients were underserved, access to healthier food may have been limited.  In addition 
to diet, lack of physical activity is associated with a higher BMI (Cugnetto et al., 2007).  
Environmental and socioeconomic status may have played a role in the amount of 
physical activity in which an individual engages.  Potential factors limiting physical 
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activity include lack of access to or unavailability of facilities or a perception that one’s 
environment is unsafe.  The race of the participants was  another factor impacting the 
population of this study.  
The majority of the participants were African American, and research indicates 
that during adolescence, African Americans are less likely to experience societal 
pressures to be thin and more likely to be influenced by members of their family (Parnell 
et al., 1996; Yates, Edman, & Aruguete, 2004).  African American women have also been 
demonstrated to show less concern about being thin than Caucasian women and are more 
flexible in their perception of beauty (Wilfey et al., 1996; Yates, Edman, & Aruguete, 
2004).   Compared to females from a variety of other races, African American women 
had the highest BMI (Yates, Edman, & Aruguete, 2004).  African American females 
constituted the largest single segment of this study’s population.  
Systolic Blood Pressure 
In systolic blood pressure, no significant differences emerged related to condition, 
time, or condition x time interaction.  The mean systolic blood pressure for the pre and 
posttest groups were both above 130, which is generally considered as stage 1 
hypertension (Tello, 2017).  Therefore, absence of change was not the result of 
individuals maintaining a healthy systolic blood pressure over time.  To the contrary, the 
observed systolic blood pressures remained in a range that would be considered mildly 
problematic.  A systolic blood pressure that is 20 points higher than the recommended 
cutoff doubles an individual’s risk for heart attack, stroke, heart failure, and aortic 
aneurysm (Tello, 2017).  Alterations in diet have proven to be the most effective front-
line treatment for high systolic blood pressure, and have lowered systolic pressure by 11 
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points or more.  Each additional healthy lifestyle change contributes a further 4- to 5-
point reduction (Tello, 2017).  In fact, dietary change alone is often prescribed for 
individuals who have hypertension, but lack any family history of cardiovascular disease 
(Tello, 2017).   
Diastolic Blood Pressure   
On DBP, no significant differences by treatment condition were present.  
However, a significant reduction appeared over time, from 80.78 to 78.62. The drop of 
2.16 units on the posttest represented exit from the elevated range.  The American 
Diabetes Association (ADA, 2017) recommendation for diastolic blood pressure is <  90, 
although it advised that individuals at high risk for cardiovascular disease may benefit 
from a target of <  80.  This significant improvement placed the study’s participants well 
within the recommended range for the general public of < 90 mmHg and also within the 
stricter guideline of < 80 mmHg for individuals at heightened risk for cardiovascular 
complications (ADA, 2017).  Research on the impact of high blood pressure has observed 
that a diastolic blood pressure 10 points above the cutoff doubles the risk of death from 
heart attack, stroke, or another cardiovascular condition, such as heart failure (Tello, 
2017).  Macrovascular complications, such as stroke, are the leading cause of death in 
patients with diabetes, causing more than 60% of fatalities (Howard et al., 2000).  
Individuals who survive a macrovascular complication are often left permanently 
disabled and/or experience significant medical consequences.   
Hemoglobin A1c 
In hemoglobin A1c, the primary dependent measure in this study, no significant 
differences by treatment condition emerged.  Nevertheless, patients improved over time, 
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regardless of the treatment they received.  In A1c, participation in treatment was 
associated with a drop of 1.36% in A1c.  Research indicated that decreases in hemoglobin 
A1c were associated with reduced mortality rates, lower risk of myocardial infarction, 
and reduction in microvascular complications (Karyekar, Frederich, & Ravichandran, 
2013).  These reductions were consistent, whether HbA1c was reduced to within the 
recommended range or not.  Additional data from the United Kingdom Prospective 
Diabetes Study (UKPDS, 1998) indicated that each 1% decrease in HbA1c correlated 
with a 21% reduction in mortality risk, a 14% reduction in myocardial infarction, and 
37% reduction in microvascular complications, such as retinopathy, nephropathy, and 
neuropathy.   
HDL Cholesterol 
Results on variable 5, HDL cholesterol, did not indicate any differences by 
condition, time, or interaction effect.  Although no significant differences were observed, 
the mean HDL cholesterol was in the normal range on the pre and posttest measure.  The 
normal range for HDL cholesterol is 40 to 59 milligrams per deciliter (mg/dl).  HDL 
cholesterol of 60 mg/dl and above is the recommended range by physicians, and HDL 
cholesterol of < 40 mg/dl increases the risk of developing heart disease.  Research results 
in the literature on the role of HDL and its connection with diabetes are mixed.  When it 
is < 40 mg/dl, studies have identified it as among a host of other variables (i.e.,  parental 
history of diabetes, elevated blood pressure, and impaired fasting glucose level) 
contributing to the development of Type 2 diabetes (Schmidt et al., 2005; Wilson, Meigs, 
& Sullivan, 2007).  Additional research indicates that HDL cholesterol combined with 
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high triglycerides is a marker for Type 2 diabetes, but does not directly impact its 
development (De Silvia et al., 2011).   
LDL Cholesterol 
Results for LDL cholesterol did not indicate differences by condition, but that 
participants’ LDL cholesterol did improve over time.  Participants’ LDL cholesterol fell 
by 14.27 points, from 110.64 to 96.37.  This reduction in LDL cholesterol signifies that 
the mean patient cholesterol in the posttest achieved the primary goal of LDL < 100 
mg/dl for the diabetic population (ADA, 2017).  Individuals who test within the 
recommended LDL cholesterol range have demonstrated a 9% reduction in all-cause 
mortality, a 21% reduction in major vascular events, and reduced risk of cardiovascular 
disease (Eldor & Raz, 2009).  Combined with the development of diabetes, LDL 
cholesterol increased the chance of cardiovascular disease by 12% (Howard et al., 2000).  
The exacerbated risk has been observed in increases of LDL cholesterol as small as 10 
mg/dl in a population of individuals between the ages of 45 and 74 (Howard et al., 2000).  
The study described LDL cholesterol as a “strong independent predictor of coronary heart 
disease in an individual with diabetes” (Howard at al., (2000) p. 830).  Thus, strong 
emphasis is placed on aggressively controlling LDL cholesterol in patients diagnosed 
with diabetes to reach the target level of  < 100 mg/dl.   
Total Cholesterol 
No differences by condition appeared in total cholesterol, but participants’ total 
cholesterol improved by 19.48 over time.  Total cholesterol is not a variable typically 
associated with diabetes management.  The literature indicates that improvement in LDL 
cholesterol level has a more direct relationship with positive health outcomes (Eldro & 
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Raz, 2009).  However, when patients have triglyceride levels of at least 200 mg per dL, 
the current guidelines recommend the use of the formula total cholesterol level minus 
HDL cholesterol level.  The target goal in the diabetic population is < 10 mg per dL 
(Armstrong, 2006).  Triglycerides were not included as an outcome variable in this study, 
but mean outcome for total cholesterol minus HDL cholesterol on the posttest measure 
would place patients in the recommended range for total cholesterol at 124.22.       
General Conclusions   
Overall, the results of the study indicate that combining additional treatment with 
IPC does not produce differential treatment effects, despite the literature’s advocation of 
the use of BHC and SMAs.  The divergence may result from PCOM’s establishment of 
an IPC model in their health care centers, which has proven to promote patient success 
without supplemental treatment.  This IPC model employs a patient-centered and team-
based approach, led by the physician, with significant collaboration between team 
members and the patients.  The team-based approach strives to provide optimum care 
across several patient domains with the goal of producing behavioral changes that will 
improve a patient’s ability to manage their diabetes effectively (ADA, 2015).   
Another potential reason for the results is that common treatment elements may 
exist across all of the three conditions, and perhaps these elements cannot be 
distinguished with complete clarity.  This implies that regardless of the type of treatment, 
parallel techniques are likely delivered across the treatment conditions.  In the present 
context, then, as part of the IPC model, PCOM physicians may actually provide patients 
with similar interventions across conditions, such as psychoeducation and motivational 
interviewing, during their typical doctor visits.  A physician employed in an IPC facility 
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may also be more familiar with the cognitive-behavioral model and may implement some 
of these techniques independently.  This may have created “bleed over” effects from one 
condition to another in the present study.   
Bleed over effects occur when treatment or program effects cross over to different 
treatment conditions than intended, and consequently make it difficult to determine if a 
treatment group member received treatment only from their assigned condition (Allen, 
Latessa & Smith, 2015).  In this study, bleed over effects may have resulted in 
individuals in the IPC condition receiving treatments also associated with BHC and 
SMAs, such as behavioral, cognitive, and motivational interviewing interventions.  
Furthermore, individuals who are patients at the same health care center are likely to 
treated by the same physicians, who could be utilizing behavioral and cognitive 
techniques during a typical office visit.  If this indeed occurs, patients in the IPC 
condition would be more likely to improve without additional treatments.  Unfortunately, 
given the archival nature of this study, it was not possible to perform a treatment integrity 
analysis to ascertain precisely what treatment modalities were delivered to patients.   
Furthermore, PCOM’s health care centers are a considered level 3 patient-
centered medical homes (PCMH).  There are 6 elements of the PCMH outlined by the 
National Committee for Quality Assurance (NCQA, 2017).  The elements are: 1) patient-
centered access, 2) team-based care, 3) population health management, 4) care 
management and support, 5) care coordination and care transitions, 6) performance 
measurement and quality improvement (NCQA, 2017).  In order to receive accreditation 
as a PCMH, each of the 6 elements must be present in the practice (NCQA, 2017).  In 
addition to incorporating each of the 6 elements, health care practices are rated on a level 
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from 1 to 3, based on a points system that indicates the degree to which the practice 
meets the NCQA requirements.  The scoring breakdown is as follows: 35-59 points 
(Level 1), 60-84 points (Level 2), and 85-100 points (Level 3) (NCQA, 2017).   
At the time of the study, the PCOM health care centers were considered to meet 
the highest standard and are designated as level 3 PCMH, according to the NCQA (2014).  
Therefore, it is incumbent upon the IPC to provide individuals with a higher level of care 
than they would receive during a visit to a primary care office that either does not 
subscribe to an IPC model or meets the criteria of a lower level PCMH.  In addition to the 
care provided in the office, the IPC emphasizes the use of resources in the community, 
such as exercise programs, senior centers, and self-help groups (Bodenheimer, Wagner, 
& Grumbach, 2002).  Research has indicated that participation in the PCHM was 
associated with better performance on such measures as weight loss and diabetes 
management, particularly improvements in hemoglobin A1c (Shi, Lee, Chung, Liang, 
Lock, & Sripipatana, 2017).   
Individuals with diabetes have been shown to have as much as a 160-200% higher 
likelihood of experiencing comorbid depression compared to the general population 
(Gonzalez et al., 2010).  The confounding variable of depression decreases the likelihood 
of a patient following through with the numerous self-care practices associated with 
successful diabetes management.  A randomized control trial was completed using patient 
data from Massachusetts General Hospital, Ferkauf Graduate School of Psychology, and 
Albert Einstein College of Medicine to examine the impact of CBT for depression and its 
effects on poorly controlled Type 2 diabetes (Safren et al., 2013).  This study specifically 
targeted the outcome variable of hemoglobin A1c as a measurement of secondary 
INTEGRATED PRIMARY CARE  65  2 
 
 
improvement associated with a reduction in depression.  Participants in the study either 
received CBT for depression plus “treatment as usual” or only “treatment as usual” 
(Safren et al., 2013).  Individuals receiving CBT for depression participated in an average 
of 9-12 sessions.  The CBT group received motivational interviewing, behavioral 
activation and mood monitoring, cognitive restructuring, problem-solving training, and 
relaxation training (Safren et al., 2013).  At the conclusion of the study, individuals who 
received a combination of CBT for depression plus treatment for diabetes as usual 
achieved a greater reduction on HbA1c, improved medication adherence, increased 
glucose monitoring, and a reduction in depression scores (Safren et al., 2013).   
As the field of integrated behavioral health care continues to grow, information 
about the patient’s response to specific levels of integration is critical.  The results of this 
study provide empirically supported information that could be used to improve the 
treatment of individuals with diabetes who have struggled to begin or maintain a 
successful diabetes management regimen.  These results offer insights into levels of 
improvement associated with each of the 3 levels of care, and the impact each level has 
on the outcome variables of BMI, cholesterol, blood pressure, and HbA1c.  The 
information can assist in adapting the necessary level of integrated care to the patient in 
order to facilitate a successful patient-tailored approach.  The role of the behavioral 
health consultant could evolve into an advocate for the patient, while simultaneously 
empowering both the patient and the treatment team. 
Information gleaned by this study also differs from the literature in the added role 
PCOM’s health care centers play as a training facilities for D.O.  students.  At PCOM, the 
SMAs are conducted with a D.O.  student and a behavioral health intern, without the 
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presence of one of the attending physicians with whom patients may have a longstanding 
relationship.  Therefore, this SMA visit may be the first time a particular patient has met 
both students.  It is possible that this in itself alters the dynamic of the visit and places the 
patient in a situation in which health care professionals with whom they are unfamiliar 
are asking them questions regarding physical and psychological health.  This poses the 
potential confounding variable of trust between the patient and their health care team 
members.  Research has shown that patient’s ratings of their physician’s interpersonal 
skills are strongly related to trust (Coulter, 2002).  The personality of the health care team 
members may unintentionally send a negative message to patients regarding their ability 
or medical knowledge.  Patients also reported common themes associated with trust, such 
as honesty, openness, responsiveness, having their best interests in mind, and willingness 
to be vulnerable (Coulter, 2002).  Patients may consequently be less likely to accept 
medical advice from health care team members with whom they have limited familiarity.  
Efforts to improve the relationship between the patient and physician have increased 
positive outcomes and levels of trust (Mainous, Baker, Love, Gray, Gill, 2001).  One way 
of achieving such improvements would entail the attending physicians meeting with 
patients prior to participation in the SMA to explain procedure and answer question, 
potentially provide a warm handoff to the other team members.   
In addition to building a relationship with the health care team from the start of 
the visit, research targeting weight loss has indicated that SMA effectiveness increased 
by extending session duration and by the SMAs meeting more frequently (Palaniappan et 
al., 2011).  At this time, no set schedule for SMAs exists at any of the pertinent health 
care center; participants may  possibly attend only one SMA.  Although participation in 
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an SMA yields a higher level of patient-centered care, attending only one session may not 
produce a significant result.  Moreover, patient follow-up with physicians after the SMA 
should be monitored.  If possible, individuals who participated in the SMA may benefit 
from referral to specific diabetes support groups as a way to increase continuity within 
the group.  Research has also demonstrated that particular patients may not be 
comfortable disclosing the severity of their illness in a group format or may suffer from 
low self-efficacy related to their ability to control their chronic illness (Due-Christensen, 
Zoffman, Hommel, & Lau, 2012).  To address these concerns, the use of cognitive 
behavioral therapy may be an important precursor to addressing potential barriers prior to 
referral to an SMA.  Other factors supporting positive SMA outcomes that should be 
considered include a low number of patients per group, providing information regarding 
the utilization of family and peer support when available, clarification of the topics 
covered in the group education sessions, and potentially increasing patient engagement 
through shared group experience (Kirsch et al., 2017).   
The study may also supplement existing literature regarding the development of 
training programs for utilization in an integrated care setting.  In addition, diabetes 
management can be taxing on physicians, possibly causing frustration when patients do 
not follow through with recommendations.  The findings also imply that a stronger 
clinical focus on diabetes management education during medical school may be 
appropriate.  This education could include training that addresses the multitude of 
variables involved in the patient’s ability to follow through with a treatment regimen.  In 
the long run, specific techniques designed to improve diabetes management may 
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potentially reduce the cost of health care, improve treatment time, and prevent diabetes 
from worsening.   
Study Limitations 
The main limitation of this study is that it is not a randomized control trial; rather 
it represents an evaluation of services provided by the PCOM health care centers.  
Evaluative research’s purpose is to assess the worth or success rates of a particular 
technique or method (Payne & Payne, 2004).  When IPC, CBT, or SMA are considered 
in this study, a number of variables potentially operate in each treatment condition.  The 
treatments delivered were not based on standardized protocols per se.  The 
nonrandomized design makes the study more susceptible to confounding variables 
between the groups, which may have impacted the results of the study.  Therefore, this 
study is best viewed as presenting a broad-stroke perspective, completed as an evaluation 
of services offered at the PCOM health care centers.  As described earlier, it is also likely 
that there were bleed over effects across the conditions that could minimize potential 
differences between them. 
When considering the results of this study, it is also important to consider 
additional unmeasured effects of participation in cognitive behavioral therapy or a SMA.  
SMAs are designed to provide additional self-management education to patients, teach 
motivational interviewing techniques, and offer peer group support (Edelman et al., 
2012).  Other outcome measures of SMAs, such as patient satisfaction, improved quality 
of care, motivation to change, and decreases in specialty and emergency room visits, 
were not measured in this study (Sanchez, 2011).  SMAs are not intended to directly 
target the parameters measured in this study, such as HbA1c.  Instead, patients learn 
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skills regarding proper diabetes management, and they are ultimately in charge of 
whether or not to employ these skills in their everyday lives.  In addition, studies have 
indicated that SMAs are associated with increased patient satisfaction, more diabetes-
related knowledge, improved self-management, lifestyle and behavior change, improved 
depression scores, increased motivation to change, increased quality of life,  and 
decreased stress (Culhane-Pera et al., 2005; Dickman, Pintz, Gold, & Kivlahan, 2012; 
Menon et al., 2017; Pieber et al., 1995; Rygg, Rise, Gronning, & Steinsbekk, 2012).   
Evidence in the literature suggests that patient motivation affected performance 
following an SMA and may impact whether or not an individual returned for an 
additional SMA.  Sanchez (2011) found that individuals deemed unmotivated to manage 
their diabetes had higher A1c levels and did not return for their follow-up SMA visit.  
Additional research conducted on a patient population diagnosed with Type 1 diabetes 
found that the benefits of a SMA were not significantly greater than a traditional visit to a 
physician on the outcome measure of HbA1c (Everest et al., 2016).  This study proposes 
SMAs as a valid alternative to a traditional medical visit. 
It should also be noted that the number of SMAs attended by the patient was not 
recorded in this study.  This may be an important factor in determining whether 
individuals who participated in multiple SMAs had better outcome measures than 
individuals who participated in fewer or only one.  It is possible that participation in more 
than one SMA may be necessary to produce a clinically significant improvement over 
IPC alone.  This possibility is consistent with Menon et al. (2017), in which African 
Americans who participated in four SMAs over a period of 6 months experienced a 
decrease in HbA1c from 8.2, to 7.1.  Moreover, research has indicated that cognitive 
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behavioral therapy positively impacts diabetes management by targeting secondary 
factors not measured in this study. 
Also, data indicating the interval between SMA and outcome measures were 
unavailable for analysis by this study.  The interval between SMA and outcome measures 
is an important consideration for future research, because individuals may experience 
stronger motivation immediately after an SMA  
Another significant limitation of this study is the lack of diversity in its 
population.  Philadelphia College of Osteopathic Medicine’s four health care centers are 
located in urban areas.  The population in this study is more likely to be affected by 
significant barriers that are less likely to be faced by individuals with a higher 
socioeconomic status.  These barriers include access to care, safe housing, insurance, and 
transportation. These individuals may require a higher level of integrated care than the 
general population, which would affect the generalizability of the results to other 
populations.  A larger scaled study would allow for more precise identification of specific 
individual factors occurring in the study’s population and so create an opportunity to 
identify specific subgroups for whom SMAs are particularly effective (Kirsh, 2017).   
The use of BMI as an outcome measure faces doubts about its utility due to 
inconsistencies in the research.  BMI was chosen because it allows a larger overall 
picture than weight loss, which fluctuates more drastically.  However, BMI has 
limitations of its own that require consideration in interpreting this study’s results.  First, 
growing concern is evident in the literature about the relationship between aging and 
BMI.  Of particular concern is the accuracy of BMI in individuals who are middle-aged 
or older, as well as in menopausal women (Prentice & Jebb, 2001).  The concern is that in 
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an aging population, the percentage of body fat increases; BMI may not accurately 
attribute increases in body fat in this group (Prentice & Jebb, 2001).   
Another variable impacting the accuracy of BMI is race and ethnicity.  Because 
BMI isa one-size-fits-all classification, differences in body type related to cultural factors 
are not included in measures of BMI.  For example, in contrast to Caucasians, other races 
and ethnicities have manifested significant differences in BMI that are acknowledged by 
the classification system (Prentice & Jebbs, 2001).  Military personnel and athletes are 
another subset of the population that may be represented inaccurately by BMI; these 
individuals have more muscle mass than the general population, which presents a greater 
likelihood of inaccurate classification as overweight or even obese (Prentice & Jebbs, 
2001).  A final potential shortcoming is that although BMI may provide a uniform 
classification system, it does not provide such critical information as the location of body 
fat.  Large amounts of upper body fat have been associated with an increase in heart 
disease and diabetes (Nuttall, 2015).  Therefore, the classification of an individual’s BMI 
alone fails to provide or assess critical information needed to identify the complete range 
of risk factors.   
Another limitation of this study is that it did not take into account the time elapsed 
since an individual was diagnosed with diabetes.  This factor may be important, because 
newly diagnosed individuals may react to their treatment regimen differently from 
individuals who were diagnosed a number of years earlier.  Self-efficacy is an important 
variable related to the interval since diagnosis.  Self-efficacy has proven to decrease in 
newly diagnosed patients who undergo an intensive diabetes treatment regimen (Thoolen, 
Ridder, Bensing, Gorder, & Rutten, 2006).  An increase in self-reported depressive 
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symptoms in newly diagnosed patients was an important confounding variable related to 
decreased self-efficacy (Thoolen, Ridder, Bensing, Gorder, & Rutten, 2006).  However, 
when self-efficacy was examined in a group of individual who were diagnosed more than 
two years earlier, it decreased when these patients received nonintensive care (Thoolen, 
Ridder, Bensing, Gorder, & Rutten, 2006).   
Physicians included in this study are mainly D.O. students drawn from a single 
osteopathic medical school.  Also, the sample size was small.  These factors may limit the 
external validity of the results.  Moreover, the study does not account for the personal 
style of the physician or behavioral health expert throughout the conditions.   
Future Directions 
  
According to the ADA (2012), a significant gap exists in the literature regarding 
SMAs in which the same standardized curriculum was implemented in both a control and 
an intervention group.  A standard SMA curriculum may help control for some of the 
confounding variables, such as the depth of the physician’s knowledge about diabetes.  In 
addition, clinical trials in which the same health care professionals provided services in 
the one-on-one and SMA visits are lacking.   No studies exist in which SMAs and 
traditional individual appointments occurred on the same day (ADA, 2012).  The 
implementation of an SMA may also be more beneficial when a professional trained 
specifically in diabetes management, such as a diabetic nurse, provided diabetes 
education (ADA, 2012).  Another gap in the literature exists concerning long-term 
monitoring of patients subsequent to participation in an SMA.  One possible explanation 
for the scarcity of data is that the implementation of the SMA is a relatively recent 
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development.  However, further data could be mined regarding potential improvement in 
participants over longer periods of time.   
The results of this study can assist in the development of a training curriculum for 
physicians that specifically target diabetes management.  The research may also offer 
advocacy for patients who might otherwise be considered as difficult to work with by 
providers.  This study also focused only on diabetes management subsequent to a 
diabetes diagnosis.  Future research targeting prediabetes and an effective course of 
treatment to prevent the development of Type 2 diabetes would be invaluable.   
In conclusion, this study only examined outcome variables regarded as directly 
linked to successful diabetes management.  However, the literature lacks consistency 
about outcome variables that can be directly attributed to BHC or SMA (Kirch, 2017).  
The study also did not investigate potential individual factors in that may affect a 
patient’s capacity to improve in those outcome variables.  Therefore, research that 
includes psychological and biological measures would be useful in exploring the 
potential impact of treatments, allowing researchers to determine whether or not 
reductions in psychological stressors improve a patient’s ability to manage diabetes 
successfully. 
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